Publication

REACH Project Scientific Publications

The Adolescent Medicine HIV/AIDS Research Network was supported by the National Institute of Child Health and Human Development, with supplemental funding from the National Institutes on Drug Abuse, Allergy and Infectious Diseases, and Mental Health and the Health Resources and Services Administration.

8
1. 5 U01 HD42 Rogers AS, Futterman D, Moscicki AB, Wilson C, Ellenberg J, and Vermund SH for the Adolescent Medicine HIV/AIDS Research Network. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health 8;22:.

9
2. 5 U01 HD42 Douglas SD, Rudy B, Muenz L, Moscicki AB, Wilson CM, Holland C, Crowley Nowick P, Vermund SH. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. AIDS 9;13:15.

3. 5 U01 HD42 Rogers AS, Schwarz DF, Weissman G, English A. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs. IRB: A Review of Human Subjects Research 9;21:6 10.

0
4. 5 U01 HD42 Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 0;:.

5. 5 U01 HD42 Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson CM, Holland C, Crowley Nowick P, Vermund SH. T lymphocyte subsets in HIV-infected and high risk HIV-uninfected adolescents - Retention of naive T lymphocytes in HIV-infected adolescents. Arch Pediatr Adolesc Med 0;:-80.

6. 5 U01 HD67 Holland C, Ellenberg JH, Wilson C, Douglas SD, Futterman D, Kingsley L, Moscicki AB. The relationship of CD4+ T cell counts and HIV-1 viral loads in untreated, infected adolescents. AIDS Res Hum Retroviruses 0;16:. (short communication)

7. 5 U01 HD67 Holland CA, Ma Y, Moscicki AB, Durako SJ, Levin L, Wilson CM. Seroprevalence and risk factors of Hepatitis B, Hepatitis C, and Human Cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the Reaching for Excellence in Adolescent Care and Health Study. Sex Transm Dis 0;27:.

8. 5 U01 HD30 Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM. Prevalence of and risks for cervical human papillomavirus infection and squamous intra-epithelial lesions in adolescent women: Impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 0;:.

9. 5 U01 HD27 Murphy DA, Durako SD, Muenz L, Wilson CM. Marijuana use among HIV+ and high-risk adolescents: a comparison of self-report through Audio Computer-Assisted Self-Administered Interviewing and urinalysis. Am J Epidemiol 0;:.

10. 5 U01 HD27 Murphy DA, Moscicki AB, Vermund SH, Muenz L. Psychological distress among HIV-positive adolescents in the REACH study: Effects of life stress, social support, and coping. J Adolesc Health 0;27:.

11. 5 U01 HD42 Rogers AS, Ellenberg JH, Douglas SD, Henry Reid L, Peralta L, Wilson C. The prevalence of anergy in human immunodeficiency virus infected adolescents and the association of delayed-type hypersensitivity with subject characteristics. J Adolesc Health 0;27:.

12. 5 U01 HD42 Sullivan KE, Cutilli J, Piliero LM, Ghavimi-Alagha D, Starr SE, Campbell DE, Douglas SD. Measurement of cytokine secretion, intracellular protein expression and messenger RNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 0;8:.

1
13. 5 U01 HD38 Belzer M, Rogers AS, Fuchs D, Camarca M, Tucker D, Peralta L, Durako S and the Adolescent Medicine HIV/AIDS Research Network. Contraceptive choices in HIV infected and HIV uninfected adolescent females. J Adolesc Health 1;29S:93-.

14. 5 U01 HD66 D’Angelo LJ, Abdalian SE, Sarr M, Hoffman N, Belzer M and the Adolescent Medicine HIV/AIDS Research Network. Disclosure of serostatus by HIV infected youth: the experience in the REACH study. J Adolesc Health 1;29S:72-79.

15. 5 U01 HD42 Douglas SD, Durako SJ, Tustin NB, Houser J, Muenz L, Starr SE, Wilson C. Natural Killer cell enumeration and function in HIV infected and high risk uninfected adolescents. AIDS Res Hum Retroviruses 1;17:.

16. 5 U01 HD33 Futterman DC, Rudy BJ, Peralta L, Wolfson S, Guttmacher S, Rogers AS and the ACCESS Project Team. The ACCESS Project (Adolescents Connected to Counseling, Evaluation, and Special Services): Social marketing to promote HIV testing to adolescents, methods and first year results from a six city campaign. J Adolesc Health 1;29S:19-29.

17. 5 U01 HD60 Levin L, Henry-Reid L, Murphy DA, Peralta L, Sarr M, Ma Y, Rogers AS and the Adolescent Medicine HIV/AIDS Research Network. Incident pregnancy rates in HIV infected and HIV uninfected at risk adolescents. J Adolesc Health 1;29S:.

18. 5 U01 HD30 Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 1;:-70.

19. 5 U01 HD27 Murphy DA, Durako SJ, Moscicki AB, Vermund SH, Ma Y, Schwarz DF, Muenz L and the Adolescent Medicine HIV/AIDS Research Network. No change in health-risk behavior over time among HIV-infected adolescents in care: role of psychological distress. J Adolesc Health 1;29S:57-63.

20. 5 U01 HD27 Murphy DA, Wilson CM, Durako SD, Muenz L and Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 1;13:27-40.

21. 5 U01 HD57 Peralta L, Durako S, Ma Y and the Adolescent Medicine HIV/AIDS Research Network. Correlation between urine and cervical specimens for the detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae using Ligase Chain Reaction in a cohort of HIV infected and uninfected adolescents. J Adolesc Health 1;29S:87-92.

22. 5 U01 HD42 Rogers AS, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, Wilson CM. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus. Clin Diagn Lab Immunol 1;8:.

23. 5 U01 HD42 Rogers AS, Miller S, Murphy DA, Tanney M, Fortune T and the TREAT Project Team. The TREAT Project (Therapeutic Regimens Enhancing Adherence in Teens): theory and preliminary results. J Adolesc Health 1;29S:30-38.

24. 5 U01 HD28 Rudy B, Douglas S, and Crowley-Nowick P. Immunology and the REACH study: HIV immunology, the research agenda, and preliminary findings. J Adolesc Health 1;29S:39-48.

25. 5 U01 HD28 Schwarz DF, Henry-Reid L, Houser J, Ma Y and the Adolescent Medicine HIV/AIDS Research Network. The association of perceived health, clinical status, and initiation of highly active antiretroviral therapy (HAART) in adolescents. J Adolesc Health 1;29S:.

26. 5 U01 HD42, P01 DE46, K15 DE59. Shiboski C, Wilson CM, Greenspan D, Hilton J, Greenspan J, Moscicki AB and the Adolescent Medicine HIV/AIDS Research Network. HIV-Related oral manifestations among adolescents in a multicenter cohort study. J Adolesc Health 1;29S:.

27. 5 U01 HD39 Sturdevant MS, Belzer M, Weissman G, Friedman LB, Sarr M, Muenz LR. The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. J Adolesc Health 1;29S:64-71.

28. 5 U01 HD42 Vermund SH, Sarr M, Murphy DA, Levin L, Abdalian SE, Ma Y, Crowley-Nowick P, Wilson CM and the Adolescent Medicine HIV/AIDS Research Network. Douching practices among HIV infected and uninfected adolescents in the United States. J Adolesc Health 1;29S:80-86.

29. 5 U01 HD42 Vermund SH, Wilson CM, Partlow C, Moscicki AB. High rates of sexually transmitted infections among HIV Infected and HIV uninfected youth: baseline prevalence and research agenda in the REACH Project. J Adolesc Health 1;29S:49-56.

30. 5 U01 HD42 Wilson CM, Ellenberg JH, Sawyer M, Belzer M, Crowley-Nowick P, Puga A, Futterman D, Peralta L. Serologic response to Hepatitis B vaccine in HIV-infected and high risk HIV uninfected adolescents in the REACH cohort. J Adolesc Health 1;29S:.

31. 5 U01 HD42 Wilson CM, Houser J, Partlow C, Futterman DC, Rudy BJ, Friedman LB and the Adolescent Medicine HIV/AIDS Research Network. The REACH Project (Reaching for Excellence in Adolescent Care and Health): study design, methods, and population profile. J Adolesc Health 1;29S:8-18.

2
32. 5 U01 HD42 Tang J, Wilson CM, Schaen M, Myracle A, Douglas SD, Kaslow RA for the REACH Study Group. Chemokine receptor CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. AIDS Res Hum Retroviruses 2;18:.

33. 5 U01 HD27 Murphy DA, Mitchell R, Vermund SH, Futterman D. Factors associated with HIV testing among HIV-positive and HIV negative high-risk adolescents: the REACH Study. Pediatrics 2;:e36.

34. 5 U01 HD28 Rudy BJ, Wilson CM, Durako S, Moscicki AB, Muenz L, Douglas SD. Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH Project. Clin Diagn Lab Immunol 2;9:.

35. 5 U01 HD42 Tang J, Wilson CM, Meleth S, Myracle A, Lobashevsky E, Mulligan MJ, Douglas SD, Korber B, Vermund SH, Kaslow RA. Host genetic profiles predict virologic and immunologic control of human immunodeficiency virus type 1 infection in adolescents. AIDS 2;16:24.

36. 5 U01 HD42 Starr SE, Sarr M, Campbell DE, Wilson CM, Douglas SD. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents. AIDS Res Hum Retroviruses 2;18:10.

3
37. 5 U01 HD30 Moscicki AB, Durako SJ, Yong M, Darragh T, Vermund SH. Utility of cervicography in human immunodeficiency virus infected and uninfected adolescents. J Adolesc Health 3;32:.

38. 5 U01 HD52 Stanford PD, Monte DA, Briggs FM, Flynn PM, Tanney M, Ellenberg JH, Clingan KL, Rogers AS. Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health 3;32:.

39. 5 U01 HD27 Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among HIV-infected adolescents. Arch Pediatr Adolesc Med 3;:.

40. 5 U01 HD42 Pham T, Belzer M, Church JA, Kitchen C, Wilson CM, Douglas SD, Geng Y, Silva M, Mitchell RM, Krogstad P. Assessment of thymic activity in HIV negative and positive adolescents using real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol 3;10:.

41. 5 U01 HD42 Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, Wilson CM for the Adolescent Medicine HIV/AIDS Research Network. Cytokine mRNA and protein for TH1 and TH2 Cytokines in HIV seropositive and HIV seronegative youth. Clin Diagn Lab Immunol 3;10:.

42. 5 U01 HD30 Moscicki AB, Houser J, Ma Y, Murphy DA, Darragh T, Farhat S, Wilson CM. Human papillomavirus infection and abnormal cytology of the anus in human immunodeficiency virus infected and uninfected adolescents. AIDS 3;.

43. 5 U01 HD42 Douglas SD, Camarca M, Durako S, Murphy D, Moscicki B, Wilson C. The relationships between substance abuse, psychosocial variables and natural killer cell enumeration and function in HIV-infected and high risk uninfected adolescents. AIDS Res Hum Retroviruses 3;19:.

44. 5 U01 HD42 Pahwa S, Chitnis V, Mitchell RM, Fernandez S, Chandrasekharan A, Wilson CM, Douglas SD. CD4 and CD8 T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy naive adolescents. AIDS Res Hum Retroviruses 3;19(6):.

45. 5 U01 HD42 Sabbaj S, Bansal A, Ritter GD, Perkins C, Edwards BH, Gough E, Tang J, Szinger JJ, Korber B, Wilson CM, Kaslow RA, Mulligan MJ, Goepfert PA. Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. JAIDS 3;33:.

46. 5 U01 HD42 Bansal A, Sabbaj S, Edwards BH, Ritter GD, Perkins C, Tang J, Szinger JJ, Weiss H, Goepfert PA, Korber B, Wilson CM, Kaslow RA, Mulligan MJ. T-cell responses in HIV Type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA Class I alleles. AIDS Res Hum Retroviruses 3;19 (11):16.

4
47. 5 U01 HD42 Wang C, Song W, Lobashevsky E, Wilson CM, Douglas S, Mytilineos J, Schoenbaum EE, Tang J, Kaslow RA. Cytokine and chemokine gene polymorpshisms among ethnically diverse North Americans with human immunodeficiency virus type 1 (HIV-1) infection. J Acq Immune Defic Syndr 4;35:.

48. 5 U01 HD42 Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA. CD8+CD38+ T cells but not HIV-1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses 4;20(3):. Correction AIDS Res Hum Retroviruses 4;20:.

49. 5 U01 HD42 Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene polymorphisms are associated with differential responses to hepatitis B vaccination. Hepatology 4;39(4):.

50. 5 U01 HD42 Kruzich LA, Marquis GS, Carriquirry AL, Wilson CM, Stephensen CB. U.S. youth in the early stage of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc 4;(7):11.

51. 5 U01 HD42 Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIV-infected U.S. youth are at high risk of obesity and poor dietary quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc 4;(10):10. (Research editorial J Am Diet Assoc 4;(10):13).

52. 5 U01 HD30 Moscicki AB, Ellenberg JH, Fahrat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and uninfected adolescent girls: risk factors and differences by phylogenetic types. J Infect Dis 4; :37-45.

53. 5 U01 HD30 Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Fahrat S. Risk of high grade squamous intra-epithelial lesions in HIV infected adolescents. J Infect Dis 4;:11.

54. 5 U01 HD42 Geisler WM, Tang J, Wang C, Wilson CM, Kaslow RA. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in north American adolescents. J Infect Dis 4;:19.

5
55. 5 U01 HD42 Stephensen CB, Marquis GS, Douglas SD, Wilson, CM. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acq Immune Defic Synd 5;38(2):.

56. 5 U01 HD42 Bansal A, Gough E, Sabbaj S, Ritter D, Yusim K, Sfakianos G, Aldrovandi G, Kaslow RA, Wilson CM, Mulligan MJ, Kilby JM, Goepfert PA. CD8+ T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS 5;19:.

57. 5 U01 HD42 Wang C, Tang, J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infections in high-risk adolescents. J Infect Dis 5;:12.

58. 5 U01 HD42 Stephensen CM, Marquis GS, Douglas SD, Wilson CM. Plasma cytokines and oxidative damage in HIV-positive and HIV-negative adolescents and young adults: A protective role for IL-10? Free Radic Res 5;39(8):.

59. 5 U01 HD27 Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, for the Adolescent Medicine HIV/AIDS Research Network. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 5;:.

60. 5 U01 HD42 Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Divergent Endocervical TH1 Cytokine Responses to Chlamydia trachomatis Infection in Adolescents. Clin Exp Immunol 5; :.

6
61. 5 U01 HD42 Stephensen CB, Marquis GS, Jacob RA, Kruzich LA, Douglas SD, Wilson CM. Vitamins C and E in adolescents and young adults with HIV infection. Am J Clin Nutr 6;83:.

62. 5 U01 HD42 Song W, Wilson CM, Allen S, Wang C, Li Y, Kaslow RA, and Tang J. Interleukin 18 and human immunodeficiency virus type 1 infection in adolescents and adults. Clin Exp Immunol 6;:.

63. 5 U01 HD30 Moscicki AB, Ellenberg JH, Murphy DA, Jiahong X. Associations among body composition, androgen levels, and human immunodeficiency virus status in adolescents. J Adolesc Health 6;39:.

64. 5 U01 HD42 Shao W, Lazaryan A, Dorak MT, Penman-Aguilar A, Wilson CM, Margolick J, Goedert J, Prins M, Tang J, Kaslow R. Cohort and Time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS, 6;20:10.

65. 5 U01 HD30 Casper C, Meier AS, Wald A, Morrow RA, Corey L, Moscicki AB. Human Herpesvirus 8 Infection Among Adolescents in the REACH Cohort. Arch Pediatr Adolesc Med, 6;: .

7
66. 5 U01 HD42 Stephensen CB, Marquis GS, , Douglas SD, Kruzich LA, Wilson CM. Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 7;85:.

67. 5 U01 HD42 Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, and Kaslow RA. CCL3L1 and CCL4L1: Variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun 7;8:.

68. 5 U01 HD42 Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA. Interleukin-10 gene (IL10) Polymorphisms and Human Papillomavirus Clearance among Immunosuppressed Adolescents. Cancer Epidemiol Biomarkers Prev 7; 16:6-32.

8
69. 5 U01 HD42 Geisler WM, Wang C, Tang J, Wilson CM, Crowley-Nowick PA, Kaslow RA. Immunogenetic Correlates of Neisseria gonorrhoeae Infection in Adolescents. Sex Transm Dis 8; 35(7):.

9
70. 5 U01 HD42 Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 9; 23(6):.

71. Tsai CS, Shepherd BE, Vermund SH. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol 9;:38.e1-38.e8.

72. 5 U01 HD42 Ding H, Wilson CM, Modjarrad K, McGwin G Jr, Tang J, Vermund SH. Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the Reaching for Excellence in Adolescent Care and Health (REACH) project. Arch Pediatr Adolesc Med 9; (12):0-5. PubMed PMID: .

0
73. 5 U01 HD42 Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, Gardner LI, McNicholl JM, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J and Kaslow RA for the HIV Epidemiology Research Study and Reaching for Excellence in Adolescent Care and Health Study. Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans. J Virol 0; 84 (5):27.

74. 5 U01 HD42 Shrestha S, Sudenga SL, Smith JS Bachmann LH, Wilson CM, and Kempf MC. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomarvirus infections in HIV-positive adolescents. BMC Infectious Diseases 0, 10:.

75. 5 U01 HD42 Shrestha S, Wiener HW, Aissani B, Song W, Shendre A, Wilson CM, Kaslow RA, and Tang J. Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents. PLoS ONE, 0: 5 (10): e84. doi:10.1/journal.pone.4. PMC5

1
76. 5 U01 HD42 Song W, Li Y, Wilson CM and Tang J. Identification of three immunologic correlates for HIV type 1 pathogenesis in youth. AIDS Res Human Retroviruses. 1; 27 (6): . PMCID pending.

77. 5 U01 HD42 Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, McNicholl JM, Gardner LI, Wilson CM, Klein RS, Rompalo A, Mayer K5, Sobel J and Kaslow RA for the HIV Epidemiology Research Study Group and Reaching for Excellence in Adolescent Care and Health Study Group. The Influence of HLA Class I Alleles and their Population Frequencies on HIV-1 Control Among African Americans. Human Immunology, 1; 72 (4): .

2
78. 5 U01 HD42 Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan E, Shrestha S. Transitional Probability-Based Model for HPV Clearance in HIV-1-Positive Adolescent Females. Plos ONE 2;7 (1) e36. doi:10.1/journal.pone.6

79. 5 U01 HD42 Sudenga SL, Kempf MC, McGwin G, Wilson CM, Hook III E, Shrestha S. Incidence, Prevalence and Epidemiology of Herpes Simplex Virus-2 in HIV-1-positive and HIV-1-negative Adolescents. Sexually Transmit Dis 2; 39 (4): .

3
80. 5 U01 HD42 Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA. Int J STD AIDS. 3; 24:. PMID: [PubMed - as supplied by publisher]

81. 5 U01 HD42 Mullins TLK, Wilson CM, Rudy BJ, Sucharew H, and Kahn JA. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sexually Transmit Dis. 3. 40(9):.

82. 5 U01 HD42 Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S. Variants in Interleukin Family of Cytokines and Toll-Like Receptor Genes Influence Clearance of High Risk HPV in HIV-1 Co-infected African-American Adolescents. Human Immunology, in press.

83. 5 U01 HD42 Johnson DC, Shrestha S, Wiener HW, Makowsky R, Kurundkar A, Wilson CM, Aissani B. Mitochondrial DNA diversity in the African American Population of the REACH Cohort. Provisionally accepted by Mitochondrial DNA.

ATN Scientific Publications

ATN Publications Word Document With Links to Manuscripts

PUBLISHED SCIENTIFIC ABSTRACTS:
4
ATN a 1. 5 U01 HD 06 Geanuracos C, Schroeder S, Perez M. Applying GIS Mapping in Program Planning and Community Relations for Youth HIV Prevention. Skill building workshop at the Global Health Council's 31st Annual Conference, Youth and Health: Generation on the Edge, June 1-4, 4, Washington, D.C. 2. 5 U01 HD 90 Rivera C, Febo I, Blasini I Ibrahim R. Epidemiological Profile of Youth 12 to 24 Year Old in Puerto Rico and Mapping Data of HIV High Risk Geographic Areas to Implement Prevention Interventions. Oral presentation at the Second Puerto Rican Conference on Public Health, September 1-3, 4, San Juan, Puerto Rico. ATN 3. 5 U01 HD 33 Constantine N, Peralta L, Sill A, Kreisel K, Griffin B, Wilson C, Rogers A. Development of an oral fluid assay capable of differentiating recent from established HIV infection. Oral presentation at Satellite Meeting, “Testing Options for Estimating HIV Incidence,” prior to the XV International AIDS Conference, July 11, 4, Bangkok, Thailand.
5
ATN 1. 5 U01 HD 33 Constantine N, Peralta L, Sill A, Kreisel K, Griffin B. Development of an oral fluid assay capable of differentiating recent from established HIV infection. Poster presentation at the CDC HIV Diagnostics Conference, February 28 - March 1, 5, Orlando, Florida.
6
ATN a 1. 5 U01 HD 84 Deeds BG, Straub DM, Willard N, Castor J, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. Fertile Ground: The Role of a Community ASSET Assessment in 15 Community-Researcher Partnerships Promoting Adolescent Health. Platform presentation at Society for Adolescent Medicine Meeting, March 22-25, 6, Boston, MA. 2. 5 U01 HD 97 Straub DM, Deeds BG, Willard N, Castor J, Peralta L, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. The Partner Selection Process: A Case Study of 15 Community-Researcher Partnerships Promoting Adolescent Health. Poster presentation at the Society for Adolescent Medicine Meeting, March 22-25, 6, Boston, MA. Abstract no. 50. ATN b 3. 5 U01 HD 33 Ziff MA, Willard N, Harper G, Bangi A, Johnson JK, Ellen JM. Longitudinal Assessments of Perceived Coalition Functioning in the Connect to Protect® Partnerships for Youth Prevention Interventions Study. Poster presentation at the 5th annual International Conference on Urban Health (ICUH), October 25-28, 6 Amsterdam, the Netherlands. ATN 4. 5 U01 HD 33 Torres RS. Relationships that Matter: Exploring Mentoring Relationships in the Lives of GBQ Male Youth. Poster Presentation at the Society for Research on Adolescence (SRA) 6 Biennial Meeting, March 23-26, San Francisco, CA. 5. 5 U01 HD 33 Harper GW, Fernandez I, Gehle J, Rodriguez A, Wilson BDM, Hidalgo MA, Torres RS, Jamil OB. Hear Me OUT!: Voices of Gay, Bisexual, and Questioning Youth. Symposium presentation at the 2nd International Congress of Qualitative Inquiry, May 4-6, 6, Champaign-Urbana, IL. ATN 6. 5 U01 HD 33 Peralta L, Sill A, Kreisel K, Griffin-Deeds B, Constantine N. Development of a less-sensitive assay using oral fluid to detect recent HIV-1 infection: A multicenter study of the Adolescent Trials Network. Abstract Book and CD Rom: XVI International AIDS Conference, August 13-18, 6 Toronto, Ontario, Canada. Abstract no. CDC6. ATN b 7. 5 U01 HD 33 Peralta L, Gorle R, Flores L, Colocho E, Boyer C, Griffin-Deeds B. Hepatitis B Vaccine Clinical Trial for Adolescents: A Model to Evaluate Strategies to Enroll Adolescents in Future HIV Vaccine Clinical Trials. Poster presentation at AIDS Vaccine 6 Conference, August 29-September 1, 6, Amsterdam, Netherlands. Abstract no. .00. ATN 8. 5 U01 HD 33 Bansal A, Yue L, Conway J, Yusim K, Kaslow RA, Wilson CM, Kappes J, Goepfert PA. Amino Acid Variation of Targeted HIV -1 Specific CD8+ T -Cell Epitopes Correlates with HLA Class I Disease Association. Oral presentation at the AIDS Vaccine 6 Conference, August 29-September 1, 6, Amsterdam, the Netherlands. ATN 9. 5 U01 HD 33 Viani R, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie Y, Weidler J, Bates M, Wilson C. Prevalence of primary HIV-1 drug resistance among recently infected adolescents; A multicenter Adolescent Trials Network Study: ATN . Oral presentation for Conference on Retroviruses and Opportunistic Infections, February 5-8, 6, Denver, CO. Abstract no. 21. ATN 10. 5 U01 HD 33 Wilson EC, Belzer M, Garofalo R, Iverson E, Martinez M, Herrick A and the Adolescent Trials Network for HIV/AIDS Interventions. Male-to-Female (MTF) transgender youth and HIV: a roundtable discussion of HIV risk within this vulnerable youth community. Poster presentation at American Public Health Association Annual Meeting, November 4-8, 6, Boston, MA. Abstract #.
7
ATN 1. 5 U01 HD 33 Naar-King S, Lam P, Wright K, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Recruitment and retention in healthy choices: a motivational intervention (MI) for HIV+ youth. Accepted for poster presentation for Annual Meeting of the Society for Adolescent Medicine, March 28-31, 7, Denver, Colorado. ATN a 2. 5 U01 HD 33 Neubauer, LC, Harper GW, Bangi AK, and Ellen J. The Quality Assurance Team (QAT): Developing Mechanisms for Multiple Voices to be heard in Transdisciplinary Multi-Site Community Research. Oral presentation at the American Evaluation Association (AEA) Conference, November 7-10, 7, Baltimore, Maryland. ATN 3. 5 U01 HD 33 Hidalgo MA. Ecological factors influencing the condom use and non-use behaviors of gay, bisexual and questioning young men. Poster presentation at APA National Multicultural Conference and Summit, January 24-26, 7, Seattle, WA. 4. 5 U01 HD 33 Jamil OB. How They Knew: Contexts of Awareness of Sexual Identity for GBQ Male Youth Oral presentation at the 3rd Annual International Congress of Qualitative Inquiry, May 2-5, 7, Champaign-Urbana, Illinois. 5. 5 U01 HD 33 Harper GW, Jamil OB, Hidalgo MA and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Gay/Bisexual/Questioning Youth of Color: Sexual Identity and the Internet. Oral presentation at the 11th Biennial Conference of the Society for Community Research and Action, June 7-10, 7, Pasadena, California. 6. 5 U01 HD 33 Fernández MI, Jamil OB, Warren JC, Hidalgo MA, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Culture, Context, and Development: HIV Prevention for Gay/Bisexual/Questioning Youth. Symposium presentation at the 11th Biennial Conference of the Society for Community Research and Action, June 7-10, 7, Pasadena, California. 7. 5 U01 HD 33 Harper GW, Fernández MI, Jamil OB, Wilson BDM, Torres RS, Warren JC, Hidalgo MA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Promoting Resilience among Gay, Bisexual, and Questioning Male Youth. Symposium presentation at the th Annual Convention of the American Psychological Association, August 17-20, 7, San Francisco, California. ATN b 8. 5 U01 HD 33 Lee S, Kapogiannis B, Cunningham C, Flynn P, Rudy D, Bethel J, Serchuck L, Ahmad S, Tucker D, Abdalian SE, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Comprehension of a simplified assent/consent form in a vaccine trial for youth. Poster presentation at the AIDS Vaccine 7 Conference, August 20-23, 7, Seattle, Washington. ATN 9. 5 U01 HD 33 Lemos D, Hosek SG, Harper GW. Provider Perceptions of the Challenges Faced by Youth Newly Diagnosed with HIV. Poster presentation at the Annual American Public Health Association Meeting, November 3-7, 7, Washington, DC. 10. 5 U01 HD 33 and 5 U01 HD 74 Lemos D. Hosek SG, Harper GW. Sources of Support for Youth during the First year Following an HIV Diagnosis. Oral presentation at the 7 National HIV Prevention Conference, December 2-5, 7. Atlanta, GA ATN 11. 5 U01 HD 33 Kiser JJ, Fletcher CV, Flynn P, Cunningham CK, Wilson CM, Kapogiannis B, Major-Wilson H, Viani RM, Muenz L, Harris B, Havens PL. and the Adolescent Trials Network. Pharmacokinetics (PK) of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate (TDF) and Atazanavir/Ritonavir (ATV/RTV) in Adolescents and Young Adults with HIV Infection - Study ATN . Oral presentation at the 8th International Workshop on Clinical Pharmacology of HIV Therapy in Budapest, Hungary April 16-18, 7. Abstract No. 12.
8
ATN 1. 4 R01 DA Finger JL, Clum G, Trent M. Desire for Pregnancy and Risk Behavior in Young HIV+ Women. Oral presentation at the Annual Meeting of the Society for Adolescent Medicine, March 26-29, 8, Greensboro, North Carolina. ATN 2. 5 U01 HD 33 Rudy B, Sleasman J. Kapogiannis B, Wilson C, Bethel J, Cunningham C, and the Adolescent Trials Network for HIV/AIDS Interventions Study Team. Short Cycle Therapy in Adolescents Following Continuous Therapy with Established Viral Suppression: The Effect on Viral Load Suppression. Poster presentation at the 15th Conference on Retroviruses and Opportunistic Infections, Feb. 3-6, 8, Boston, Massachusetts. Abstract # . ATN 3. 5 U01 HD 33 Serrano P, Harper GW, Fernandez MI. Internet's Role in Sexual Health of Gay/Bisexual/Questioning Adolescents. Oral presentation at the Annual American Public Health Association Meeting October 25-29, 8, San Diego, California. ATN 4. 5 U01 HD 33 Sill A, Constantine N, Wilson C, Peralta L, The Adolescent Trials Network for HIV/AIDS Interventions. Demographic, Clinical, Risk Profiles and Rates of Recent Infection among HIV-Infected Adolescents and Young Adults. CD-ROM publication from the XVII International AIDS Conference, August 3-8, 8, Mexico City, Mexico. Abstract No. CDC1 ATN 5. 5 U01 HD 33 Cunningham CK, Rudy BJ, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn PM. Seroresponse to 2-Dose Hepatitis B Immunization among Youth at Adolescent Clinics (ATN). Poster presentation at the Pediatric Academic Societies & Asian Society for Pediatric Research Joint Annual Meeting, May 3-6, 8, Honolulu, Hawaii. ATN 6. 5 U01 HD 33 Lemos D, Hosek S, Adolescent Trials Network. Disclosing for the First Time: Thoughts and Experiences of Youth Living with HIV. Poster presentation at the XVII International AIDS Conference, August 3-8, 8, Mexico City, Mexico, Abstract No. MOPE9 PCS 7. 5 U01 HD 33 Gilliam PP, Ellen JM, Leonard L, Kinsman S, and Straub DM. Transitional Care for Adolescents with HIV. Poster presentation at the Annual Meeting of the Society for Adolescent Medicine, March 26-29, 8, Greensboro, North Carolina. 9 ATN b 1. 5 U01 HD 33 and 5 U01 HD 74 Jennings JM, Ellen JM, Deeds BG, Harris DR, Muenz LR, Barnes W, Lee S, Auerswald CL, and the Adolescent Medicine Trials Network for HIV / AIDS Interventions. Recent Partner-Specific HIV Transmission Risk for Youth Living with HIV. Poster presentation at the Annual Meeting of the Society for Adolescent Medicine, March 25-28, 9, Los Angeles, California. Abstract No. 29 ATN a 2. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Monte D, Harris R, Stosze S, Emmanuel P, Hardin D, Kapogiannis B, Worrell C, Wilson C, Aldrovandi GM. Metabolic abnormalities in young behaviorally HIV-infected women: preliminary results for Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) – ATN . Poster presentation for the Conference on Retroviruses and Opportunistic Infections, February 8-11, 9, Montreal, Canada. Abstract No. ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Flynn PM, Rudy B, Wilson C, Kapogiannis B, Worrell C, Bethel J, Monte D, and Cunningham CK. Improving Seroresponse to Hepatitis B Vaccination in HIV-Infected Adolescents: ATN . Accepted 06/12/09 for poster presentation for the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 9, Cape Town, South Africa. 4. 5 U01 HD 33 and 5 U01 HD 74 Flynn PM, Rudy B, Wilson C, Kapogiannis B, Worrell C, Bethel J, Monte D, and Cunningham CK. Improving Seroresponse to Hepatitis B Vaccination in HIV-Infected Adolescents: ATN . Accepted 06/25/09 for poster presentation for the 1st International Workshop on HIV Pediatrics, July 17-18, 9, Cape Town, South Africa. ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Brennan J, Stauffer A and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Syndemic Theory and HIV-related Risk Among Young Transgender women: The Role of Multiple, Co-Occurring Health Problems. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 9, Puerto Vallarta, Jalisco, Mexico. ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Freeman PF, Robles-Schrader GM, and Ellen J. Systems changes to promote sexual literacy. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 9, Puerto Vallarta, Jalisco, Mexico. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Castillo M, Palmer B, Ellen J, Willard N, The Adolescent Trials Network, Connect to Protect® Philadelphia. Implementing HIV Prevention, Awareness, and Testing in the Ballroom Community. Poster presentation at the American Public Health Association Annual Meeting, November 7-11, 9, Philadelphia, PA. 8. 5 U01 HD 33 and 5 U01 HD 74 Castillo M, Lin A, Ellen J, Willard N, The Adolescent Trials Network, Connect to Protect® Philadelphia. HIV Prevention for Housing Insecure LGBT Youth. Poster presentation at the American Public Health Association Annual Meeting, November 7-11, 9, Philadelphia, PA. ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Lemos D, Hosek SG, Harper GW and the Adolescent Medicine Trials Network for HIV / AIDS Interventions. Peer Facilitator Involvement with Youth Newly Diagnosed with HIV: Lessons Learned from Project ACCEPT. Submitted 12/11/08; Accepted 05/05/09 for Oral presentation at the CDC National HIV Prevention Conference, August 23-26, 9, Atlanta Georgia. Abstract No. 10. 5 U01 HD 33 and 5 U01 HD 74 Lemos D, Hosek SG and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Process Evaluation of a Gender-Specific Sexuality Session for Youth Recently Diagnosed with HIV. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 9, Puerto Vallarta, Jalisco, Mexico. ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper GW and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Operating without a safety net: Gay male adolescents' responses to marginalization and migration and implications for theory of syndemic production of health disparities. Oral presentation at the American Public Health Association Annual Meeting, November 7-11, 9, Philadelphia, PA. 12. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Timmons A, LoPresto J, Ackron T, Rood B, Bruce D and the ATN Protocol Team. Drugs, Sex, Condoms: Cultural Messages Influencing HIV+ Black Gay/Bisexual Youth. Oral presentation at the American Public Health Association Annual Meeting, November 7-11, 9, Philadelphia, PA. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Brothers J, Hosek SG and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. From Their Mouths to Our Ears: What Young HIV+ Women Perceive to be Their Biggest Challenges and What They Want from Targeted Interventions. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 9, Puerto Vallarta, Jalisco, Mexico. 0 ATN b 1. 5 U01 HD 33 and 5 U01 HD 74 Straub D, Arrington-Sanders R, Harris R, Willard N, Futterman D, Kapogiannis B, Emmanuel P, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. HIV testing of high risk youth: what do we know about those who don’t get tested? Accepted 10/15/09 for poster presentation at the Annual Meeting of the Society for Adolescent Medicine, April 7-10, 0, Toronto, Ontario, Canada ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Bruce D, Rogers, and the Adolescent Trials Network for HIV/AIDS Interventions. Attraction, Dating and Sex: Implications for the Sexual Health of Gay/Bisexual Male Youth. Approved for submission 02/05/10. Oral presentation at the American Public Health Association Conference, November 6-10, 0, Denver, CO ATN 3. 5 U01 HD 33 and 5 U01 HD 74 McGoy S, Hurd-Sawyer L, and Williams A. Taking it to the Streets-Partying with a Purpose. Accepted for oral presentation at the NACCHO Annual 0 Conference, July 14-16, 0, Memphis, TN. 4. 5 U01 HD 33 and 5 U01 HD 62 Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Poster presentation at the 0 HIV Prevention Leadership Summit in Washington, DC, December 12-15, 0. 5. 5 U01 HD 33 and 5 U01 HD 62 Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Submitted 11/04/10. Poster presentation at the International Conference on STIGMA in Washington, DC, December 1, 0. ATN b 6. 5 U01 HD 33 and 5 U01 HD 74 Lopez B, Gassama M, Bruce D, Spiegel H, Futterman D, and the Adolescent Trials Network for HIV/AIDS Interventions. HIV and STI Rates and Trends among Youth in the Bronx from 5 to 8. Poster presentation at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 0. 7. 5 U01 HD 33 and 5 U01 HD 74 Camacho M, Jones, Gonzalez, Ellen J, and the ATN, C2P Manhattan. Religious and Spiritual Beliefs Among Black and Latino YMSM -- Implications for Partnerships in HIV Prevention. Oral presentation at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 0. ATN - Local 8. 5 U01 HD 33 and 5 U01 HD 74 Freeman P, Cooper-Walker B, Ellen JE, Garofalo R and the Adolescent Trials Network for HIV/AIDS Interventions. YMSM who report using methamphetamine: Recruitment venues and HIV-related risk behavior. Accepted for oral presentation at the Annual Meeting of the Society for Adolescent Medicine, April 7-10, 0, Toronto, Ontario, Canada. ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Maxwell D, Allota, Jones, Camacho M, Ellen J, and the ATN, C2P Manhattan. Outspoken -- Using Media and Community Partnerships to Adapt the CDC DEBI Community PROMISE. Oral presentation at a special session at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 0. ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Ventuneac A, Carballo-Diéguez A, Khan J, Zimet G, Leu, Giguere R, Mabragaña, McGowan, and the Adolescent Trials Network for HIV/AIDS Interventions. Use of Telephone and Web-based Technology to Monitor Adherence. Poster presentation at the 0 International Microbicides Conference, May 22-25, 0, Pittsburgh, PA. 11. 5 U01 HD 33 and 5 U01 HD 74 Carballo-Diéguez A, Giguere R, Chen B, Dolenzal C, Khan J, Zimet G, Mabragaña M, Lee S, McGowan I, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability Lessons Learned in a Phase 1 Microbicide Trial Involving Product Use During Vaginal Intercourse. Poster presentation at the 0 International Microbicides Conference, May 22-25, 0, Pittsburgh, PA. ATN 12. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Havens P, and the ATN. Evidence of Renal Tubular Impairment and Increased Bone Turnover in HIV-infected Adolescents and Young Adults on Tenofovir-containing cART: Baseline Results of the Adolescent Trials Network (ATN) Study . Oral presentation at the 12th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, November 4-6, 0, London, UK. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Harper G, Lemos D, and the ATN. Project ACCEPT: A Behavioral Intervention to Improve Engagement in Care for HIV-Positive Youth. Poster presentation at the 0 National Summit on HIV Diagnosis, Prevention & Access to Care in National Harbor, MD, November 17-19, 0 ATN 14. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Bruce D, Hosek S, Fernandez M, and the Adolescent Trials Network for HIV/AIDS Interventions. Resilience among Gay/Bisexual Male Youth Living with HIV: Implications for Intervention. Oral presentation at the International AIDS Society Convention, July 18-23, 0, Vienna, Austria. 15. 5 U01 HD 33 and 5 U01 HD 74 LoPresto J, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Influences of Social Support and HIV on Gay Identity Development. Accepted for presentation at the American Psychological Association Annual Convention, August 12-15, 0, San Diego, CA. 16. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Fernandez M, Jamil O, Hildago M, Torres S, and the Adolescent Trials Network for HIV/AIDS Interventions. An Empirically-Based Transactional Model of Same-Sex Sexual Orientation Identity Development. Accepted for presentation at the American Psychological Association Annual Convention, August 12-15, 0, San Diego, CA. ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Brothers J, Rodriguez, Hosek S, and the Adolescent Trials Network for HIV/AIDS Interventions. A Mixed but Colorful Bag: The Benefits and Challenges of Involving Young HIV-Positive Women in the Design and Development of a Secondary Prevention Intervention. Poster presentation at the International AIDS Society Convention, July 18-23, 0, Vienna, Austria. ATN 18. 5 U01 HD 33 and 5 U01 HD 74 Lally M, Goldsworthy, Sniecinski K, and Zimet G. Development of Tools to Reduce Preventive Misconception in HIV Vaccine Trials among Adolescents. Poster presentation at the 0 AIDS Vaccine Conference in Atlanta, GA, September 28 - October 1, 0. 1 ATN b 1. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Harris R, Emmanuel P, Fielding R, Hardin D, Worrell C, Kapogiannis B, Monte D, Sleasman J, Aldrovandi G and the ATN b Study Team. Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy (ART) Adolescent Trials Network (ATN) Protocol b. Poster presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 1. ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Wilson E. Parental support and HIV-related risk behavior among transgender female youth. Oral presentation to the 1 National Transgender Health Summit, April 8-9, 1, San Francisco, CA. ATN 3. 5 U01 HD 33 and 5 U01 HD 62 Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Poster presentation at the 32nd Annual Minority Health Conference, February 25, 1, webcast. 4. 5 U01 HD 33 and 5 U01 HD 74 Lin A, Castillo M, Gwiazdowski B, and the Adolescent Trials Network for HIV/AIDS Interventions. Enhancing youth-based housing services and HIV prevention through community engagement; A successful model for identifying and implementing structural changes for homeless LGBT adolescents. Roundtable presentation at the 1 American Public Health Association conference, October 29-November 2, 1, Washington, D.C. 5. 5 U01 HD 33 and 5 U01 HD 62 Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Oral presentation at the American Public Health Association Meeting, Oct. 29 – Nov. 2, 1, Washington, D.C. 6. 5 U01 HD 33 and 5 U01 HD 74 Robles-Schrader G, Lewis C, Roy J. Hitting the Mark: Using Root Cause Analysis to Identify Structural Changes Aimed at Addressing the HIV Epidemic. Accepted 08/05/11 for oral presentation at the 1 US Conference on AIDS Pre-Conference Institute, Chicago, IL, November 9, 1. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Baheti G, Brundage RC, Kiser JJ, Havens P, Fletcher CV, and the Adolescent Trials Network for HIV/AIDS Interventions. Plasma and Intracellular Population Pharmacokinetics Analysis of Tenofovir in HIV-1 Infected Patients. Poster presentation to the 1 American Conference on Pharmacometrics (ACoP), April 3-6, 1, San Diego, CA ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Agwu A, Bethel J, Hightow-Weidman L, Sleasman J, Wilson C, Rudy B, Kapogiannis B. Substantial Multiclass Transmitted Drug Resistance and Drug-Relevant Polymorphisms Among Treatment-naïve Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Study. Poster presentation at the 1 International AIDS Society Meeting, July 17-20, 1, Rome, Italy. ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Havens P, Hazra R, Stephensen C, van Loan M, Rutledge B, Bethel J, Pan C, Liu N, Lujan-Zilbermann J, Mulligan K, and the Adolescent Trials Network (ATN) study team. Vitamin D3 (VITD) Supplementation Decreases Parathyroid Hormone (PTH) in HIV-infected Youth Being Treated with Tenofovir (TDF)-containing Combination Antiretroviral Therapy (cART): a Randomized, Double-blind, Placebo-controlled Multicenter Trial (RCT): Ad. Oral presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 1. 10. 5 U01 HD 33 and 5 U01 HD 74 Havens P, Mulligan K, Hazra R, Van Loan M, Pan C, Bethel J, Rutledge B, Kapogiannis B, Flynn P, Lujan-Zilbermann J, Kiser J, Baker A, Liu N, Wilson C, Stephensen C and the Adolescent Trials Network (ATN) study team. Safety and efficacy of once-monthly dosing of Vitamin D 3 (50, IU) in HIV-infected youth: ATN . Oral presentation at the 13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, July 14-16, 1, in Rome Italy. ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Squires K, Zimet G, Xu J, Gonin R, Liu N, Dillard M, and the ATN. Risk Perceptions after Human Papillomavirus Vaccination in HIV-Infected Adolescent and Young Adult Women. Poster presentation at the 27th International Papillomavirus Meeting, September 17-32, 1, in Berlin, Germany. 12. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Burk R, Squires K, Kapogiannis B, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson C, and the ATN. HPV Epidemiology in HIV-Positive Young Women Receiving Their First HPV Vaccination. Poster presentation at the 27th International Papillomavirus Meeting, September 17-32, 1, in Berlin, Germany. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Heavy Marijuana Use among Young HIV-Positive Gay and Bisexual Men. Poster presentation to the 1 Society of Behavioral Medicine conference, April 27-30, 1, Washington, D.C. 14. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual Risk Behavior and Secondary Prevention Beliefs among Young HIV-Positive MSM. Poster presentation at the 1 American Public Health Association conference, October 29-November 2, 1, Washington, D.C. ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Alexander A, Ott M, Lally M, Zimet G, and the ATN. Preventive Misconception and Adolescents' Knowledge about HIV Vaccine Trials. Oral presentation at the 1 Society for Adolescent Health and Medicine annual meeting in Seattle, Washington, March 29 - April 1, 1. ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Syed SS, Balluz RS, Kabagambe EK, Wilson CM, Sleasman J, Kapogiannis B, Nachman S. ATN : Longitudinal Changes in Cardiovascular Risk Markers Among HIV Infected and At Risk Adolescents. Poster presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 1. ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin M, Duval A, Ellen J, Kapogiannis B, Dunbar E, Fortenberry JD. Linking adolescents infected with HIV into care: The effects of relationships between local health departments and adolescent medicine clinics. Oral presentation to the 1 American Public Health Association conference, October 29-November 2, 1, Washington, D.C. 18. 5 U01 HD 33 and 5 U01 HD 74 Philbin M, Tanner AE, Duval A, Ellen J, Kapogiannis B, Dunbar E, Fortenberry JD. Models of Linkage to Care for newly diagnosed HIV-positive adolescents within fifteen Adolescent Medicine Clinics in the United States. Oral presentation to the 1 American Public Health Association conference, October 29-November 2, 1, Washington, D.C. 2 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Giguere R, Zimet G, Kahn J, Dolezal, Mabragaña, Carballo-Diéguez A, and the Adolescent Trials Network for HIV/AIDS Interventions. The Motivations and Experiences of Young Women in a Microbicide Trial. Oral presentation to the 2 International Microbicides Conference in Sydney, Australia, April 15-18, 2. ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Havens PL, Mulligan K, Hazra R, Van Loan MD, Rutledge BN, Pan CG, Flynn PM, Lujan-Zilberman J, Gordon CM, Woodhouse LR, Kiser J, Meyer WA, Baker AM, Liu NX, Wilson CM, Stephensen CB. Increase in Fibroblast Growth Factor 23 (FGF23) in response to Vitamin D3 supplementation in HIV-infected adolescents and young adults on tenofovir-containing cART: Adolescent Trials Network (ATN) study . Oral presentation at the 14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV in Washington, D.C., July 19-21, 2. ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Xu J, Kapogiannis B, Rudy BJ, Liu N, Gonin R, Wilson C, Worrell C, Squires K, and the Adolescent Trials Network for HIV/AIDS Interventions. Immunogenicity of the HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women. Oral presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. ATN 4. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Kahana S, Harper G, Fernandez MI, and the Adolescent Trials Network for HIV/AIDS Interventions. Alcohol Use Predicts Sexual Risk Behavior with HIV-Negative or Partners of Unknown Status Among Young HIV-Positive Men Who Have Sex with Men. Poster presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. 5. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Fernandez MI, Bruce D, Hosek S, Jacobs R, and the Adolescent Trials Network for HIV/AIDS Interventions. The Role of Multiple Identities in Engagement in Care among Gay/Bisexual Male Adolescents Living with HIV. Oral presentation to the 2 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2. ATN / 6. 5 U01 HD 33 and 5 U01 HD 74 Nichols S, Sleasman J, Goodenow M, Lowe A, Hou W, Garvie P, Patton D, Zhang X, and the Adolescent Trials Network for HIV/AIDS Interventions. Substance use self-report by adolescents with HIV: How valid is it? Poster presentation to the 4th International Workshop on HIV Pediatrics in Washington, DC, July 20-21, 2. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Siberry G, Lally M, Bell M, Fernandez MI, Rutledge B, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. A First Look at Open Label Use of Pre-Exposure Prophylaxis among Young Men Who Have Sex with Men. Poster presentation to the 4th International Workshop on HIV Pediatrics in Washington, D.C. July 20-21, 2. ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Hightow-Weidman L, Boyer C, Li S, Vellala K, Gonin R, Henry-Reid L, Futterman D, Maturo D, Straub D, Siberry G, Kapogiannis B, Gassama M, Lopez B, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Exploring the Sexual Relationships of HIV-positive and Negative Black and Hispanic Young Women and their Male Sexual Partners. Poster presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. ATN 9. 5 U01 HD 33 and 5 U01 HD 62 Fortenberry J, Brown R, Humphreys M, Martinez M and the Adolescent Trials Network for HIV/AIDS Interventions. CDC-ATN/NICHD Testing and Linkage to Care Project: An update on multisite initiative to improve LTC for HIV positive youth. Poster presentation to the 2 National African American MSM Leadership Conference on HIV/AIDS and other Health Disparities in New Orleans, LA, January 19-22, 2. 10. 3 U01 HD 33 - ARRA Philbin M, Tanner AE, Duval A, Ellen J, Kapogiannis B, Fortenberry JD. Linkage to care and engagement in care for newly diagnosed HIV-positive youth within fifteen Adolescent Medicine Clinics in the United States. Poster presentation at the 2 Society for Adolescent Health and Medicine conference in New Orleans, LA., March 14-17, 2. 11. 3 U01 HD 33 - ARRA Tanner AE, Philbin M, Duval A, Ellen J, Kapogiannis B, Fortenberry JD. The importance of “youth friendly” clinical environments for linking newly diagnosed HIV-positive adolescents to care. Poster presentation at the 2 Society for Adolescent Health and Medicine conference in New Orleans, LA., March 14-17, 2. 12. 5 U01 HD 33 and 5 U01 HD 74 Kapogiannis B, Fortenberry JD, Ellen J, Xu J, Willard N, DuVal A, Pace J, Loeb J, Bethel J, Wilson C, the ATN Team, and the Adolescent Trials Network for HIV/AIDS Interventions. The Strategic Multisite Initiative for the Identification, Linkage and Engagement to Care of HIV-Infected Youth (SMILE): Can Treatment As Prevention Work for American Minority Youth? Poster presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. 13. 5 U01 HD 33 and 5 U01 HD 74 Philbin M, Tanner A, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care. Poster presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. 14. 5 U01 HD 33 and 5 U01 HD 74 Tanner A, Philbin M, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Models of relationships between local health departments and adolescent medicine clinics: Importance for adolescent HIV linkage to care. Oral presentation to the International AIDS Society Conference in Washington, DC, July 22-27, 2. 15. 5 U01 HD 33 and 5 U01 HD 74 Kapogiannis B, Fortenberry JD, Ellen J, Xu J, Willard N, DuVal A, Pace J, Loeb J, Bethel J, Wilson C, the ATN Team, and the Adolescent Trials Network for HIV/AIDS Interventions. The Strategic Multisite Initiative for the Identification, Linkage and Engagement to Care of HIV-Infected Youth (SMILE): Can Treatment As Prevention Work for American Minority Youth? Poster presentation to the 4th International Workshop on HIV Pediatrics in Washington, D.C. July 20-21, 2. 16. 5 U01 HD 33 and 5 U01 HD 74 Philbin M, Tanner A, DuVal A, Ellen J, Kapogiannis B, and Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Understanding linkage to care and engagement in care across 15 Adolescent Medicine Trials Network (ATN) clinics: Adolescent provider perspectives and implications for newly HIV-infected youth. Oral presentation to the 2 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2. 17. 5 U01 HD 33 and 5 U01 HD 74 Tanner A, Philbin M, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Linking HIV-positive adolescents to care: The role and process of ‘youth friendly’ clinical environments. Poster presentation to the 2 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2. 3 ATN 1. 5 U01 HD 33 and 5 U01 HD 62 Stines S, Walker BC, Willard N, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Structural Approaches for HIV Prevention among Young Men and Transgender Women of Color who have Sex with Men. Poster presentation to the International Conference on STIGMA in Washington, DC, November 22, 3. ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Nichols S, Bethel J, Garvie P, Patton D, Thornton S, Kapogiannis B, Ren W, Li S, Major-Wilson H, Woods S, and the Adolescent Trials Network for HIV/AIDS Interventions. Neurocognitive Functioning in Antiretroviral Therapy-Naïve Youth with Behaviorally Acquired HIV. Poster presentation to the 3 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA, March 3-6, 3. ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Outlaw AY, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. Oral presentation to the International Society for Research on Internet Interventions (ISRII) 6th Scientific Meeting in Chicago, IL, May 16-18, 3. 4. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Outlaw AY, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. Oral presentation to the American Psychological Association 3 Meeting in Honolulu, HI, July 31-August 4, 3. ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Belzer M, Naar-King S, Olson J, Clark L, Sarr M, and the Adolescent Trials Network for HIV/AIDS Interventions. A Pilot Study Using Cell Phone Interactions to Improve HIV Medication Adherence in Adolescents Who Have Previously Failed Antiretroviral Therapy. Oral presentation to the 3 Society for Adolescent Health and Medicine Annual Meeting in Atlanta, GA, March 13-16, 3. ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Telander K, Balthazar C, Lally M, Siberry G, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. Does Sexual Behavior Influence Adherence to Pre-Exposure Prophylaxis? Data from a PrEP Trial among Young Men Who Have Sex with Men. Poster presentation to the 3 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA, March 3-6, 3. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Nellum A, Williams A, and the Adolescent Trials Network for HIV/AIDS Interventions. Connecting to Protect: Implications of a CBPR Approach to Illustrate Geospatial Patterns of Adolescent HIV/STI Risk Indicators. Poster presentation to the st APHA Annual Meeting in Boston, MA, November 2-6, 3. 4 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Rudy BJ, Kapogiannis B, Bethel J, Wilson CM, Worrell C, Li S, Squires K, Goodenow M, Agwu A, Sleasman J, and the Adolescent Trials Network for HIV/AIDS Interventions. HIV Therapy De-intensification to Atazanavir/ritonavir (ATVr) Monotherapy in Adolescents/Young Adults Maintain CD4 Gains and VL Suppression. Oral presentation to the 21th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, March 3-6, 4. ATN 2. 5 U01 HD 33 and 5 U01 HD 74 McGregor K, Ott M, Lally M, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Adolescent Decision Making about HIV Vaccine Trial Participation. Oral presentation to the 4 Society for Social Work and Research Conference in San Antonio, TX, January 15-19, 4. 3. 5 U01 HD 33 and 5 U01 HD 74 Zimet GD, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Lally M, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluation of Interventions to Improve Adolescents’ Understanding about an HIV Vaccine Clinical Trial. Poster presentation to the 4 Society of Pediatric Psychology Annual Conference in Philadelphia, PA, March 27-29, 4. 4. 5 U01 HD 33 and 5 U01 HD 74 Zimet GD, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Lally M, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluation of Interventions to Improve Adolescents’ Understanding about an HIV Vaccine Clinical Trial. Poster presentation to the symposium at the Society for Developmental and Behavioral Pediatrics Meeting, Nashville, TN, September 19-22, 4. ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Belzer M, Clark L, Kahana S, Sarr M, Thornton S, Olson J, Naar-King S, and the Adolescent Trials Network for HIV/AIDS Interventions. A Randomized, Controlled Pilot Study of Cell Phone Support for Youth Nonadherent to ART: Impact of the Intervention on Depression, Substance Abuse and Service Utilization. Poster presentation to the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 4. 6. 5 U01 HD 33 and 5 U01 HD 74 Belzer M, MacDonell KK, Naar-King S, Kahana S, Sarr M, Thornton S, Huang J, Olson J, Clark L, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV Nonadherent to Antiretroviral Therapy (ART). Oral presentation to the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 4. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Martinez J, Santos K, Balthazar C, Serrano P, Bojan K, Mehrotra M, Grant R, and the Adolescent Trials Network for HIV/AIDS Interventions. PrEP Interest, Uptake and Adherence among Young Men Who Have Sex with Men (YMSM) in the United States. Poster presentation to the 4 Conference of Retrovirus and Opportunistic Infections (CROI) in Boston, MA, March 3-6, 4. ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Wilson PA, Kahana SY, Fernandez MI, Harper G, Wilson C, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Health-related and Psychosocial Correlates of Sexual Risk Behavior among HIV-positive Young Men Who Have Sex with Men in the United States. Poster presentation to the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 4. ATN / 9. 5 U01 HD 33 and 5 U01 HD 74 Gross IM, Hosek S, Richards M, Fernandez MI, Huszti H, and the Adolescent Trials Network for HIV/AIDS Interventions. Using Optimal Data Analysis to Predict Antiretroviral Adherence among HIV+ Youth. Poster presentation to the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 4. 10. 5 U01 HD 33 and 5 U01 HD 74 Saberi P, Mayer K, Vittinghoff E, Naar-King S, and the Adolescent Trials Network for HIV/AIDS Interventions. Correlation between Use of Antiretroviral Adherence Devices by HIV-infected Youth and Plasma HIV RNA and Self-reported Adherence. Poster presentation to the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 4. 11. 5 U01 HD 33 and 5 U01 HD 74 Brown, LK, Whitely, L, Harper, GW, Nichols, S, Nieves, A, the ATN Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Mental Health Symptoms among Youth Living with HIV. Poster presentation to the 4 American Academy of Child & Adolescent Psychiatry (AACAP) conference, San Diego, CA, October 20-26, 4. 12. 5 U01 HD 33 and 5 U01 HD 74 Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, Rubin D and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Health and Psychosocial Outcomes Among HIV+ Young Transgender Women Engaged in Medical Care. Approved by BLG 10/13/14. Poster Presentation to the National CFAR Meeting, Providence, RI, November 5-7 4. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Miller RL, Janulis PF, Reed SJ, Fortenberry JD, Kapogiannis BG, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluating Referral Infrastructures to Support Youth Linkage to HIV Care. Poster presentation to the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 4. 14. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin MM, DuVal A, Ellen JM, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. An overview of the SMILE program: Care linkage and engagement for newly diagnosed HIV+ adolescents within fifteen adolescent medicine clinics in the United States. Oral presentation to the Society for Prevention Research 22nd Annual Meeting in Washington, DC, May 27-30, 4. ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Nichols S, Lowe A, Zhang X, Garvie P, Thornton S, Goldberger B, Hou W, Goodenow M, Sleasman JW, and the Adolescent Trials Network for HIV/AIDS Interventions. Concordance Between Self-Reported Substance Use and Toxicology Among HIV Infected and Uninfected at Risk Youth. Poster presentation to the 4 Southern HIV and Alcohol Research Consortium Conference in Miami, FL, January 29-30, 4. ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML, and the Adolescent Medicine Trials Network. Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Adolescents. Poster presentation to the 29th International Papillomavirus Conference in Seattle, August 21-25, 4. ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. Poster presentation to the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 4. 18. 5 U01 HD 33 and 5 U01 HD 74 Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. Poster Presentation at the 6th International Workshop on HIV Pediatrics, Melbourne, Australia, July 18-19, 4. 5 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Nichols S, Garvie P, Li T, Ren W, Kapogiannis B, Rudy B, Sleasman J, Woods S, Puga A, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Neurocognition following antiretroviral initiation in behaviorally HIV-infected youth. Poster Presentation to the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, February 23-26, 5. 2. 5 U01 HD 33 and 5 U01 HD 74 Garvie PA, Li S, Bethel J, Woods SP, Patton ED, Nichols SL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Poster presentation to the 10th International Conference on HIV Treatment and Prevention Adherence that will be held in Miami, FL, June 28-30, 5. ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Emslie G, Brown L, Kennard B, Mayes T, Xu J, Garvie P, Worrell C, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Treatment of Depression in Adolescents and Young Adults with HIV. Oral presentation at the 10th International Conference on Child and Adolescent Psychopathology, London, England, July 20-22, 5. 4. 5 U01 HD 33 and 5 U01 HD 74 Brown L, Kennard B, Emslie G Mayes T, Xu J, Whiteley L, Hawkins L, Garvie P, Tanney M, Stoff L, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Treatment of Depression in Adolescents and Young Adults with HIV. Poster presentation at the National HIV Prevention Conference hosted by the CDC, Atlanta, GA, December 6-9, 5. ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin M, DuVal A, Ellen J, Kapogiannis B, Fortenberry D and the Adolescent Trials Network for HIV/AIDS Interventions. Transitioning adolescents with HIV to adult care: Examining processes at twelve adolescent medicine clinics. Poster presentation to the 5 Society for Adolescent Health and Medicine (SAHM) Annual Meeting, Los Angeles, CA, March 18-21, 5. ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Zhang X, Nichols S, Chang K, Kaiki M, Sleasman J, Chi Y, Goodenow M, and the Adolescent Trials Network for HIV/AIDS Interventions. Substance use effects on neurocognitive and immune function among HIV-infected youth. Poster Presentation to Southern HIV and Alcohol Research Consortium (SHARC) Conference, Gainesville, FL, January 28-29, 5. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Lemos D, Hosek S, Harper G, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Project ACCEPT: A behavioral intervention to promote engagement in care for youth newly diagnosed with HIV. Oral presentation to the 10th International Conference on HIV Treatment and Prevention Adherence that will be held in Miami, FL, June 28-30, 5. ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Wilson CM, and the Adolescent Trials Network for HIV/AIDS Interventions. An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM ages 18-22 in the United States. Oral presentation at the 8th IAS Conference on HIV Pathogenesis, Vancouver, BC, Canada, July 19-22, 5. 9. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Rutledge B, Kapogiannis B, Siberry G, Anderson, Landovitz R, Rudy B, Liu N, Rooney J, Havens P, Wilson CM, Hosek S, ATN protocol team and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Bone Changes in Young Men Ages 18-22 Enrolled in a Pre-Exposure Prophylaxis (PrEP) Demonstration Project Using Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC). Oral presentation at the 17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, Barcelona, Spain, October 21-24, 5. ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Siberry G, Serrano P, Hosek S, Liu N, Brothers J, Lee S, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. Recruitment Methods for a Pre-Exposure Prophylaxis (PrEP) Study with Adolescent and Young Adult Men Who Have Sex with Men (MSM). Oral presentation at the 7th International Workshop on HIV pediatrics, Vancouver, B.C., Canada, July 17-28, 5. ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Gilbert A, Knopf A, Fortenberry D, Hosek S, Kapogiannis B, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Self-Consent for Biomedical HIV Prevention Research: Implications for IRB Approval and Implementation. Poster presentation to the 5 Society for Adolescent Health and Medicine (SAHM) Annual Meeting, Los Angeles, CA, March 18-21, 5. 12. 5 U01 HD 33 and 5 U01 HD 74 Knopf A, Gilbert A, Fortenberry D, Kapogiannis B, Hosek S, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Implementing a multi-site HIV prevention trial requiring adolescent self-consent: Challenges encountered and lessons learned. Approved by CPLG 09/15/14. Accepted 12/19/14 as a poster presentation to the Midwest Nursing Research Society 39th Annual Research Conference, Indianapolis, IN, April 16-19, 5. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Kapogiannis B, Xu J, Mayer K, Loeb J, Greenberg L, Monte D, Koenig L.J., Bank-Shields M, Fortenberry D , and the Adolescent Trials Network for HIV/AIDS Interventions. The HIV Continuum of Care for Adolescents and Young Adults (12-24 years) Attending 13 Urban US Centers of the NICHD-ATN- CDC-HRSA SMILE Collaborative. Poster presentation at the 8th IAS Conference on HIV Pathogenesis, Vancouver, BC, Canada, July 19-22, 5. ATN 14. 5 U01 HD 33 and 5 U01 HD 74 Hartlieb K, Naar-King S, Lam P, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Nationwide Implementation of Motivational Interviewing Training to Enhance Youth Linkage to HIV Care in the US. Poster presentation to the 10th International Conference on HIV Treatment and Prevention Adherence that will be held in Miami, FL, June 28-30, 5. ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Jadwin-Cakmak L, Reisner S, Martinez M, Solomon L, Campbell B, Popoff E, and the Adolescent Trials Network for HIV/AIDS Interventions. Exploring Utilization of HIV related Services and Care among Transgender and Other Gender Minority Youth in the U.S. Approved by BLG 12/12/14. Accepted 02/13/14 as an oral presentation to the National Transgender Health Summit, Oakland, CA, April 17-18, 5. Accepted Abstracts 1. 5 U01 HD 33 and 5 U01 HD 74 Chutuape K, Muyeed A, Willard N, Greenberg L, Ellen J and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adding to the HIV Prevention Portfolio: The Achievement of Structural Changes by Coalitions Targeting to Reduce HIV Risk in Adolescents and Young Adults through Community Mobilization in Urban Areas Across the US and Puerto Rico. Approved by the CPLG Chair 08/25/15. Accepted as an oral presentation at the Society for Adolescent Health and Medicine Conference, Washington D.C., March 9-12, 6. (ATN ) 2. 5 U01 HD 33 and 5 U01 HD 74 L. Wilson, R. Gakpo, G. Aldrovandi, B. Rudy, M. Goodenow, J. Sleasman and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Lymphocyte Activation and Bone Turnover in HIV-infected Young Adults; a sub-study Adolescent Trials Network Protocol . Approved by TLG 08/27/5. Accepted 11/24/5 to the 6 Annual Meeting of the American Academy of Asthma, Allergy and Immunology, Los Angeles, CA March 4-7, 6. (ATN ) 3. 5 U01 HD 33 and 5 U01 HD Tanner A, Fortenberry JD, Philbin M, Lally M, Ma A, Chambers B, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transition for adolescent to adult HIV care for youth across 15 clinics in the United States: Preliminary results from Project CATCH. Approved by CPLG 12/28/15. Accepted 02/15/16 as an oral presentation at the 6 IAS 2nd Adolescent Transition Workshop, Budapest, Hungary, April 6, 6. (ATN ) Submitted Abstracts 1. 5 U01 HD 33 and 5 U01 HD 74 Mullins T, Zimet G, Lally M, Xu J, Thornton S, Kahn J and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Clinician Intention to Prescribe and Actual Prescription of PrEP to At-Risk Youth. Approved by CPLG 09/28/15. Submitted 01/20/16 to the 21st International AIDS Society Conference, Durban, South Africa, July 18-22, 6. (ATN ) 2. 5 U01 HD 33 and 5 U01 HD 74 Miller RL, Lindeman P, Chiaramonte D, Fortenberry JD, Boyer C, Chutuape K, Cooper-Walker B and the Adolescent Medicine Trials Network for HIV/AIDS Interventions Evaluating Testing Strategies for Identifying High-risk Youth and Linking Youth to Prevention. Approved by CPLG 02/24/16. Submitted 02/04/16 to the 21st International AIDS Society Conference, Durban, South Africa, July 18-22, 6. (C2TaP) Pending Submission None. PUBLISHED SCIENTIFIC PAPERS
5
1. 5 U01 HD74 Mitchell R, Shah M, Ahmad S, Rogers AS, Ellenberg JH, Adolescent Medicine Trials Network for HIV / AIDS Interventions, A unified web-based Query and Notification System (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials. Clinical Trials 5;2:61-71(11). PMID:
6
ATN a 1. 5 U01 HD 33 Ziff MA, Harper GW, Chutuape KS, Deeds BG, Futterman D, Francisco VT, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Laying the foundation for Connect to Protect®: A multi-site community mobilization intervention to reduce HIV/AIDS incidence and prevalence among urban youth. J Urban Health, 6;83(3):. DOI:10.7/s11-7 ATN 2. 5 U01 HD 33 Bansal A, Gough E, Ritter GD, Wilson CM, Mulenga J, Allen SA, Goepfert PA. Group M-based HIV-1 Gag peptides are frequently targeted by T-cells in chronically infected US and Zambian patients. AIDS, 6;20(3):. PMID: 3. 5 U01 HD 33 Turnbull EL, Lopes AR. Jones NA, Cornforth D, Aldam D, Newton P, Pellegrino P, Williams I, Flower DR, Goepfert PA, Maini MK, Borrow P. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol, 6; : 0–6. PMID: ATN 4. 5 U01 HD 33 Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study. J Infect Dis, 6;:19. PMID: ATN 5. 5 U01 HD 33 Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Wilson CM. Vitamin D Status in Adolescents and Young Adults with HIV Infection. Am J Clin Nutr, 6;83:5-41. PMID
7
ATN 1. 5 U01 HD 33 Murphy DA, Hoffman D, Seage GR, Belzer M, Xu J, Durako S, Geiger M, and the Adolescent Trials Network for HIV/AIDS Interventions. Improving comprehension for HIV vaccine trial information among adolescents at risk for HIV. AIDS Care, 7; 19(1):42-51. PMID ATN 2. 4 R01 DA Trent M, Chung S, Clum G, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. New sexually transmitted infections among adolescent girls infected with HIV. Sex Transm Infect, 7; 83:. PMID ATN a 3. 5 U01 HD 97 Straub DM, Deeds BG, Willard N, Castor J, Peralta L, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Partnership Selection and Formation: A Case Study of Developing Adolescent Health Community-Researcher Partnerships in 15 U.S. Communities. J Adolesc Health, 7;40:. PMID 4. 5 U01 HD 06 Geanuracos C, Cunningham SD, Weiss G, Forte D, Henry-Reid LM, Ellen JM and the Adolescent Trials Network for HIV/AIDS Interventions. Use of geographic information systems for HIV prevention intervention planning for high-risk youth. Am J Public Health, 7; 97:11. PMID ATN 5. 5 U01 HD 33 Harper GW, Jamil OB, Wilson BDM. Collaborative community-based research as activism: giving voice and hope to lesbian, gay, and bisexual youth. Journal of Gay and Lesbian Psychotherapy, 7;12:99-. DOI: 10.0/Jv11n03_06 ATN 6. 5 U01 HD 33 Sill A, Kreisel K, Deeds BG, Wilson CM, Constantine NT, Peralta L, Adolescent Trials Network for HIV/AIDS Interventions. Calibration and validation of an oral fluid-based sensitive/less sensitive assay to distinguish recent from established HIV-1 infections. J Clin Lab Anal, 7:21:40-45. PMID ATN 7. 5 U01 HD 33 Yu XG, Lichterfeld M, Chetty S, LaBute MX, Williams KL, Mui SK, Miura T. Frahm N, Feeney ME, Tang Y, Pereyra F, Pfafferott K, Leslie A, Crawford H, Allgaier R, Hildebrand W, Kaslow R, Brander C, Allen TM, Rosenberg ES, Altfeld M, Kiepiela P, Vajpayee M, Goepfert PA, Goulder PJR, Walker BD. Mutually exclusive T-cell receptor induction and differential susceptibility to Human Immunodeficiency Virus Type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol , 7: 81:11. PMID 8. 5 U01 HD 33 Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA. Immunological control of chronic HIV-1 Infection: analyses of HLA-mediated immune function and viral evolution in adolescents. AIDS, 7;21(18):27. PMID
8 1. 5 U01 HD 33 and 5 U01 HD 74 Jaspan HB, Cunningham CK, Tucker TJP, Wright PF, Self SG, Sheets RL, Rogers AS, Bekker L-G, Wilson CM, Duerr A, Wasserheit J, and the HIV Vaccine Adolescent Trials Working Group. Inclusion of Adolescents in Preventive HIV Vaccine Trials: Public Health Policy and Research Design at a Crossroads. J Acquir Immune Defic Syndr, 8; 47:86-92. PMID ATN 2. 4 R01 DA Leonard L, Ellen JM. “The Story of My Life”: AIDS and ‘Autobiographical Occasions’. Qual Sociol, 8:31:37-56. http://www.springerlink.com/content/wr22jr0/fulltext.html PMCID 8 ATN a 3. 5 U01 HD 84 Deeds BG, Straub DM, Willard N, Castor J, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. Fertile Ground: The Role of a Community Resource Assessments in the Development of 15 Adolescent Health Community-Researcher Partnerships. Progress in Community Health Partnerships: Research, Education, and Action. 8:2(1):31-39. The Role of Community Resource Assessments in the Development of 15 Adolescent Health Community-Researcher Partnerships 4. 5 U01 HD 33 and 5 U01 HD 74 Sánchez-Cesáreo M, Harper GW, Neubauer L, Cellar D, Doll M, Robles G, Johnson J, Bangi A, Ellen J. Building bridges between organization development and community psychology: An integrative model for multi-site community based research. Interamerican Journal of Psychology, 8; 42 (2):1-10. No PMID available. http://find.galegroup.com/gtx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T&prodId=IFME&docId= A3&source=gale&srcprod=IFME&userGroupName=birm26&version=1.0 5. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Neubauer LC, Bangi AK, Francisco VT, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transdisciplinary Research and Evaluation for Community Health Initiatives. Health Promotion Practice, 8; 9 (4):. PMID PMCID 0 ATN b 6. 5 U01 HD 33 and 5 U01 HD 74 Deeds BG, Castillo M, Beason Z, Cunningham SD, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. An HIV Prevention Protocol Reviewed at 15 National Sites: How do Ethics Committees Protect Communities? Journal of Empirical Research on Human Research Ethics, 8;3(2):77-86. http://caliber.ucpress.net/doi/pdf/10.5/jer.8.3.2.77’ ATN 7. 5 U01 HD 33 Warren JC, Fernández MI, Harper G, Hidalgo M, Jamil O, Torres RS. Predictors of Unprotected Sex among Young Sexually Active African American, Hispanic, and White MSM: The Importance of Ethnicity and Culture. AIDS Behav, 8:2(1):31-39. PMID PMCID 0 ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Hosek SG, Harper GW, Lemos D, Martinez J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. An Ecological Model of Stressors Experienced by Youth Newly Diagnosed with HIV. Journal of HIV/AIDS Prevention in Children and Youth, 8; 9(2):. PMID PMCID 6 ATN 9. 5 U01 HD 33 Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL, and the Adolescent Trials Network for HIV/AIDS Interventions. Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir/Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection. Antimicrob Agents Chemother, 8;52:. PMID PMCID 5 9 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Parsons JT, Murphy DA, Chen X, Harris DR, Belzer M and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Improving Health Outcomes for Youth Living with HIV: A Multisite Randomized Trial of a Motivational Intervention Targeting Multiple Risks. Arch Pediatr Adolesc Med. 9;(12):18. PMCID 9 ATN 2. 4 R01 DA Clum G, Chung S, Ellen J. Mediators of HIV-Related Stigma and Risk Behavior in HIV Infected Young Women. AIDS Care, 9 Nov;21(11):5-62. PMID: PMCID 9 ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Rudy B, Sleasman J, Kapogiannis B, Wilson C, Bethal J, Ahmad S, Cunningham CK and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Short-Cycle Therapy in Adolescents Following Continuous Therapy with Established Viral Suppression: The Impact on Viral Load Suppression. AIDS Res Hum Retroviruses, June 9, 25(6): . PMID PMCID 6 ATN b 4. 5 U01 HD 33 and 5 U01 HD 74 Chutuape KS, Ziff M, Auerswald C, Castillo M, McFadden A, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Examining Differences in Types and Location of Recruitment Venues for Young Males and Females from High-Risk Neighborhoods. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 8; 85. PMID . PMID PMCID 4 5. 5 U01 HD 33 and 5 U01 HD 74 Jennings JM, Ellen JM, Griffin-Deeds B, Harris DR, Muenz LR, Barnes W, Lee S, Auerswald CL, and the Adolescent Trials Network for HIV/AIDS Interventions. Youth Living with HIV and Partner-specific Risk for the Secondary Transmission of HIV. Sex Transm Dis, July 9, 36(7): . PMID PMCID 8 ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Jamil OB, Harper GW, Fernandez MI and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual and Ethnic Identity Development among Gay/Bisexual/Questioning (GBQ) Male Ethnic Minority Adolescents. Cultur Divers Ethnic Minor Psychol, 9, 15(3): –. PMID PMCID 9 ATN b 7. 5 U01 HD 33 and 5 U01 HD 74 Rudy BJ, Murphy DA, Harris R, Muenz L, Ellen J. Patient-Related Risks for Non-Adherence to Antiretroviral Therapy among HIV-Infected Youth in the United States: A Study of Prevalence and Interactions. AIDS Patient Care and STDs, March 9, 23 (3):. PMID PMCID 3 ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Wilson EC, Garofalo R, Harris DR, Herrick A, Martinez J, Martinez M, Belzer, M. and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav, 9 Oct;13(5):-13. PMID PMCID 8 ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Clear and Independent Associations of Several HLA-DRB1 Alleles with Different Antibody Responses to Hepatitis B Vaccination in Youth. Human Genetics. July 9. DOI 10.7/s00-z. PMID PMCID 1 ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Clum G, Andrinopoulos K, Muessig K, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Child Abuse in Young HIV Positive Women: Linkages to Risk. Qual Health Res 9;19:5. PMID PMCID 8 0 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Murphy DA, Lam P, Naar-King S, Harris DR, Parsons JT, Muenz LR and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Health Literacy and Antiretroviral Adherence Among HIV-infected Adolescents. Patient Educ Couns, 0; 79: 25-29. PMID PMCID 7 2. 5 U01 HD 33 and 5 U01 HD 74 Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H, ATN Protocol Team, Adolescent Trials Network for HIV/AIDS Interventions. Multiple Risk Behaviors among Youth Living with Human Immunodeficiency Virus in Five US Cities. J Adolesc Health, 0 Jan;46(1):11-16. PMID NIHMS PMCID 2 3. 5 U01 HD 33 and 5 U01 HD 74 Outlaw AY, Naar-King S, Janisse H, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Condom Use in a Multi-Site Study of High-Risk Youth Living with HIV. AIDS Educ Prev, 0 Feb: 22(1), 1-14. PMID PMCID 2 4. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Kolmodin K, Parsons JT, Murphy D, Wright K and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Psychosocial Factors and Substance Use in High Risk Youth Living with HIV: A Multisite Study. AIDS Care, 0 Apr; 22(4):-82. PMID PMCID 9 5. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Parsons JT, Murphy DA, Kolmodin K, Harris DR. and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression. J Adolesc Health, 0 May; 46(5):-8. PMID PMCID 0 6. 5 U01 HD 33 and 5 U01 HD 74 MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW ATN Protocol Team, Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Medication Adherence in High Risk Youth of Color Living with HIV. J Pediatr Psychol, 0 Jul; 35(6):. PMID PMCID 1 7. 5 U01 HD 33 and 5 U01 HD 74 Nugent NR, Brown LK, Belzer M, Harper GW, Nachman S, Naar-King S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk. J Int Assoc Physicians AIDS Care, 0 Mar-Apr;9(2):-5. PMID PMCID ATN 8. 4 R01 DA Dietz ERM, Clum G, Chung S, Leonard L, Murphy DA, Perez L, Harper G, Ellen JM. Adherence to scheduled appointments among HIV-infected female youth in five US cities. J Adolesc Health, 46 (0) –. PMID PMCID 6 ATN b 9. 5 U01 HD 33 and 5 U01 HD 74 Ziff MA, Willard N, Harper GW, Bangi AK, Johnson J, Ellen JM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Connect to Protect® Researcher-Community Partnerships: Assessing Change in Successful Collaboration Factors over Time. Global Journal of Community Psych Practice, 0 Jan 14; 1(1): 31-39. PMID 6 PMCID 10. 5 U01 HD 33 and 5 U01 HD 74 Barnes W, D’Angelo L, Belzer M, Schroeder S, Palmer-Castor J, Futterman D, Kapogiannis B, Muenz L, Harris DR, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Identification of HIV Infected 12-24 Year Old Men and Women in Fifteen US Cities Through Venue-Based Testing. Arch Peds & Adol Med, 0;(3):. PMID PMCID 0 ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Wilson BDM, Harper GW, Hidalgo MA, Jamil OB, Torres RS Fernandez MI, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Negotiating Dominant Masculinity Ideology: Strategies used by Gay, Bisexual and Questioning Male Adolescents. Am J of Community Psychol, 0; 45:. PMID: PMCID 5 ATN a 12. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Harris DR, Monte D, Stoszek S, Emmanuel P, Hardin DS, Kapogiannis BG, Worrell C, Meyer WA, Sleasman J, Wilson CM, Aldrovandi GM. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network (ATN) Study . Clin Infect Dis, 0;50:. PMID PMCID 9 ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Sill AM, Constantine NT, Wilson CM, Peralta L. Demographic Profiles of Newly Acquire HIV Infections Among Adolescents and Young Adults in the U.S. J Adolesc Health, 0;46: 93–96. PMID PMCID 9 ATN b 14. 5 U01 HD 33 and 5 U01 HD 74 Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen JE and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Prevalence and Interactions of Patient-Related Risks for Non-Adherence to Antiretroviral Therapy among Perinatally-Infected Youth in the United States. AIDS Patient Care STDs, 0; 24(2): 97-. PMID PMCID 3 ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Cunningham CK, Rudy BJ, Xu J, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn P, and the Adolescent Trials Network for HIV/AIDS Interventions. Randomized Trial to Determine Safety and Immunogenicity of Two Strategies for Hepatitis B Vaccination in Healthy Urban Youth in the United States. Pediatr Infect Dis J, 0 Jun;29(6):-4. PMID ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Dolcini MM, Harper GW, Boyer CB, Pollack LM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Project ORE: A Friendship-Based Intervention to Prevent HIV/STI in Urban African American Adolescent Females. Health Educ Beha, 0 Feb;37(1):-32. PMID PMCID 2 ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Wilson EC, Garofalo R, Harris DR, Herrick A, Martinez J, Martinez M, Belzer, M., the TAC, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Sexual risk taking among transgender male-to-female youths with different partner types. Am J of Public Health 0 Aug; (8):0-5. PMID PMCID 3 ATN 18. 5 U01 HD 33 and 5 U01 HD 74 Chutuape KS, Willard N, Sanchez K, Straub DM, Ochoa TN, Howell K, Rivera C, Ramos I, Ellen JM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Mobilizing Communities around HIV Prevention: How Three Coalitions Applied Key Strategies to Bring about Structural Changes. AIDS Educ Prev, 22(1), 15-27, 0. PMID PMCID 6 ATN 19. 5 U01 HD 33 and 5 U01 HD 74 Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K, and the Adolescent Trials Network for HIV/AIDS Interventions. Impaired Generation of Hepatitis B Virus-specific Memory B Cells in HIV Infected Individuals Following Vaccination. Vaccine 0 May 7;28(21):2-8. PMID PMCID 2 1 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 MacDonell K, Naar-King S, Murphy D, Parsons J Huszti H. Situational Temptation for HIV Medication Adherence in High Risk Youth. AIDS Patient Care and STDs, 1 Jan;25(1):47-52. PMID PMCID pending 2. 5 U01 HD 33 and 5 U01 HD 74 Chen X, Murphy D, Naar-King S, Parsons J. A Clinic-Based Motivational Intervention Improves Condom Use Among Subgroups of Youth Living with HIV – A Multicenter Randomized Controlled Trial. J Adolesc Health, 1 Aug;49(2):-8. PMID PMCID 7 ATN 3. 4 R01 DA Andrinopoulos K, Clum G, Murphy DA, Harper G, Perez L. Xu J, Cunningham S, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Health Related Quality of Life and Psychosocial Correlates among HIV-infected Adolescent and Young Adult Women. AIDS Educ Prev, 1 Aug;23(4):-81. PMID NIHMSID ATN b 4. 5 U01 HD 33 and 5 U01 HD 74 Straub D, Arrington-Sanders, Harris, Willard N, Kapogiannis B, Emmanuel P, Futterman D, Ellen J and the ATN. Correlates of HIV Testing History among Urban Youth Recruited through Venue-Based Testing in 15 US Cities Sexually Transmitted Diseases. Sex Transm Dis, 1 Aug;38(8):. PMID: PMC7 (available on 2/8/1) 5. 5 U01 HD 33 and 5 U01 HD 74 Freeman P, Cooper B, Garofalo R, Willard N, Ellen J and the ATN. Methamphetamine Use and Risk for HIV Among Young Men who have Sex with Men in Eight U.S. Cities. Arch Pediatr Adolesc Med. 1 Aug;(8):. PMID NIHMSID ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Flynn P, Cunningham C, Rudy B, Wilson C, Kapogiannis B, Worrell C, Bethel J, Monte D, Bojan K. Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens. J Acquir Immune Defic Syndr, 1 Apr;56(4):-32. PMID PMCID 8 ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Baheti G, Kiser J, Havens P, Fletcher C, and the Adolescent Medicine Trials Network. Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1 Infected Patients. Antimicrobial Agents and Chemotherapy, 1 Nov; 55(11):59. (ATN ) PMID: PMCID 6 ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Gilliam PP, Ellen JM, Leonard L, Kinsman S, Jevitt CM, Straub DM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transition of Adolescents with HIV to Adult Care: Characteristics and Current Practices of the Adolescent Trials Network. J Assoc Nurses AIDS Care, 1 July;22(4):. PMID NIHMSID ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Giguere R, Carballo-Dieguez A, Ventuneac A, Magbragana M, Dolezal C, Chen B, Kahn J, Zimet G, McGowan I, and the Adolescent Medicine Trials Network. Variations in microbicide acceptability among young women in the USA and Puerto Rico. Culture, Health & Sexuality 2 Feb;14(2):-66. PMID NIHMSID ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Fernandez MI, Hosek S, Warren J, Jacobs, Martinez J, and the ATN. Development of an Easy to Use Tool to Assess Adolescent's HIV Treatment Readiness in Clinical Care Settings. AIDS Care, 1 Nov;23(11):2-9. PMID PMCID 1 [Available on 2/11/1] ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Lemos D, Harper G and Telander. Evaluating the Acceptability and Feasibility of Project ACCEPT: An Intervention for Youth Newly Diagnosed with HIV. AIDS Educ Prev, 1 Apr;23(2):-44. PMID NIHMSID ATN 12. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Operating Without a Safety Net: Gay Male Adolescents’ Responses to Marginalization and Migration, and Implications for Theory of Syndemic Production of Health Disparities. Health Educ Behav, 1 Aug;38(4):. PMID PMCID 4 2 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Dempsey AG, Garner R, Naar-King S, Lau CY. Patterns of Disclosure among HIV Positive Youth: A Multisite Study. J Adolesc Health, 2 Mar;50(3):-7. PMID 0 PMCID 7 [Available on 3/3/1] 2. 5 U01 HD 33 and 5 U01 HD 74 Tanney M, Naar-King S, MacDonell K, and the ATN. Depression and Stigma in High Risk Youth Living with HIV: A Multisite Study. J Pediatr Health Care, 2 Jul;26(4):-5. PMID PMCID 3 3. 5 U01 HD 33 and 5 U01 HD 74 Murphy D, Chen, Naar-King S, Parsons J and the ATN. Alcohol and Marijuana Use Outcomes in the Healthy Choices Motivational Interviewing Intervention for HIV-positive Youth. AIDS Patient Care STDs 2 Feb;26(2):95-. PMID PMCID 8 ATN 4. 4 R01 DA and 5 U01 HD 33 Martinez J, Harper G, Carlton, Hosek S, Bojan K, Clum GA, and the Adolescent Medicine Trials Network. The Impact of Stigma on Medication Adherence among HIV-Positive Adolescent Women and the Moderating Effects of Coping and Satisfaction with Health Care. AIDS Patient Care STDs 2 Feb;26(2):-15. PMID PMCID 9 5. K01 MH , 4 R01 DA 5, and U01 HD 33 Finger JL, Clum GA, Trent ME, and Ellen JM. Desire for Pregnancy and Risk Behavior in Young HIV+ Women. AIDS Patient Care and STDs 2 Mar;26(3):. PMID PMCID 7 6. 4 R01 DA Clum GA, Chung SE, Ellen JM, Perez LV, Murphy D, and Harper GW. Victimization and Sexual Risk Behavior in Young, HIV Positive Women: Exploration of Mediators. AIDS Behav, 2 May;16(4):0. PMID PMCID 4 ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Torres RS, Harper GW, Sanchez B, Fernandez MI. Examining Natural Mentoring Relationships among Self-Identified Gay, Bisexual, and Questioning (GBQ) Male Youth. Child Youth Serv Rev, 2 Jan; 34(1):8-14. PMC Journal - in process 8. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper G, Fernandez MI, Jamil OB, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Age-Concordant and Age-Discordant Sexual Behavior among Gay and Bisexual Male Adolescents. Arch Sex Behav, 2 Apr;41(2):-8. PMID PMCID 0 [Available on 2/8/3] 9. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Brodsky, Bruce D, and the ATN. What's Good about Being Gay?: Perspectives from Youth. J LGBT Youth, 2 Winter;9(1):22-41. PMID PMCID 3 ATN b 10. 5 U01 HD 33 and 5 U01 HD 74 Mulligan K, Harris DR, Emmanuel P, Fielding RA, Worrell C, Kapogiannis BG, Monte D, Sleasman J, Wilson CM, Aldrovandi GM and the Adolescent Medicine Trials Network. Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy: Adolescent Trials Network (ATN) Study B. Clin Infec Dis 2 Aug;55(3):. PMID PMCID 7 ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Wilson EC, Iverson E, Belzer M, Garofalo R, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Parental support and condom use among transgender female youth. J Assoc Nurses AIDS Care, 2 Jul;23(4):-17. PMID PMCID 6 12. 5 U01 HD 33 and 5 U01 HD 74 Brennan J, Garofalo R, Johnson, Kuhns, Belzer M, Wilson E, and the Adolescent Medicine Trials Network. Syndemic Theory and HIV-related Risk among Young Transgender Women: The Role of Multiple, Co-Occurring Health Problems. Am J Public Health, 2 Sep;(9):17. PMID PMCID 8 ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Castillo M, Palmer B, Rudy BJ, Fernandez MI, Ellen J, and the ATN. Creating partnerships for HIV prevention among YMSM: the Connect to Protect Project and House and Ball Community in Philadelphia. J Prev Interv Community 40:2, . NIHMSID 14. 5 U01 HD 33 and 5 U01 HD 74 Lin A, Dudek J, Francisco VT, Castillo M, Freeman P, Martinez M, Sniecinski K, Young K, Ellen J and the ATN. Challenges and approaches to mobilizing communities for HIV prevention among young men who have sex with men of color. J Prev Interv Community 40:2, . NIHMSID 15. 5 U01 HD 33 and 5 U01 HD 74 Harper, G.W., Willard, N., Ellen, J., & the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Connect to Protect®: Utilizing community mobilization and structural change to prevent HIV infection among youth. J Prev Interv Community 40:2, 81-86. NIHMSID 16. 5 U01 HD 33 and 5 U01 HD 74 Doll M., Harper G, Robles-Schrader G, Johnson J., Bangi, A., Velagaleti, S, & the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Perspectives of community partners and researchers about factors impacting coalition functioning over time. J Prev Interv Community 40:2, 87-. NIHMSID 17. 5 U01 HD 33 and 5 U01 HD 74 Robles-Schrader G, Harper G, Purnell, and Monarrez. Differential Challenges in Coalition Building among HIV Prevention Coalitions Targeting Specific Youth Populations. J Prev Interv Community 40:2, . NIHMSID 18. 5 U01 HD 33 and 5 U01 HD 74 Willard N, Chutuape K, Stines S, and Ellen JM, & the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Bridging the Gap Between Individual Level Risk for HIV and Structural Determinants: Using Root Cause Analysis in Strategic Planning. J Prev Interv Community 40:2, . PMID PMCID 9 ATN 19. 5 U01 HD 33 and 5 U01 HD 74 Martinez J, Lemos D, Hosek S, and the Adolescent Medicine Trials Network. Stressors and Sources of Support: The Perceptions and Experiences of Newly Diagnosed Latino Youth Living with HIV. AIDS Patient Care STDs 2 26(5):. PMID PMCID 5 ATN 20. 5 U01 HD 33 and 5 U01 HD 74 Agwu A, Bethel J, Hightow-Weidman L, Sleasman J, Wilson C, Rudy B, Kapogiannis B, and the Adolescent Medicine Trials Network. Substantial Multiclass Transmitted Drug Resistance and Drug-Relevant Polymorphisms among Treatment-Naïve Behaviorally HIV-Infected Youth: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Study. AIDS Patient Care STDs 2 28(4):. PMID PMCID 7 ATN 21. 5 U01 HD 33 and 5 U01 HD 74 Carballo-Dieguez A, Giguere R, Dolezal C, Chen B, Kahn J, Zimet G, Mabragana M, Leu CS, McGowan I, and the Adolescent Medicine Trials Network. “Tell Juliana”: Acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a Phase 1 microbicide study. AIDS Behav, 2 Oct;16(7):1-74. PMID PMCID 8 ATN 22. 5 U01 HD 33 and 5 U01 HD 74 Havens P, Stephenson C, Hazra R, Flynn P, Wilson C, Rutledge B, Bethel J, Pan C, Woodhouse L, Van Loan M, Liu N, Lujan-Zilberman J, Baker A, Kapogiannis B, Mulligan K and the Adolescent Medicine Trials Network. Vitamin D3 Decreases Parathyroid Hormone in HIV-infected Youth Being Treated with Tenofovir: a Randomized, Placebo-Controlled Trial. Clin Infect Dis, 2 Apr;54:15. PMID PMCID 0 23. 5 U01 HD 33 and 5 U01 HD 74 Havens, Mulligan, Hazra, Flynn, Rutledge, Van Loan, Lujan-Zilberman, Kapogiannis, Wilson, Stephensen, the ATN study team, and the Adolescent Medicine Trials Network. Serum 25-hydroxy vitamin D3 Response to Vitamin D3 50, IU Monthly in Youth with HIV-1 Infection. J Clin Endocrinol Metab, 2 Nov;97(11):43. PMID PMCID 4 ATN 24. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Xu, Zimet G, Liu N, Gonin R, Dillard M, Squires K, and the Adolescent Medicine Trials Network. Risk Perceptions after Human Papillomavirus Vaccination in HIV-Infected Young Women. J of Adolesc Health, 2 May;50(5):-70. PMID PMCID 5 25. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Burk R, Squires K, Kapogiannis B, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson C, and the Adolescent Medicine Trials Network. Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination. J Acquir Immune Defic Syndr, 2 Nov 1;61(3):. PMID PMCID 5 ATN a 26. 5 U01 HD 33 and 5 U01 HD 74 Fortenberry JD, Martinez J, Rudy BJ, Monte D, and the Adolescent Medicine Trials Network. Linkage to care for HIV-positive Adolescents: A multi-site study of the Adolescent Medicine Trials Units of the Adolescent Trials Network. J Adolesc Health, 2 Dec;51(6):-6. PMID PMCID 3 ATN 27. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper G. Future Life Goals of HIV-Positive Gay and Bisexual Male Emerging Adults. J Adolesc Res, 2 Jul;27(4):. PMID PMCID 4 ATN 28. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Brothers J, Lemos D and the ATN. What HIV-Positive Young Women Want from Behavioral Interventions: A Qualitative Approach. AIDS Patient Care STDs, 2 May;26(5):-7. PMID PMCID 4 ATN 29. 5 U01 HD 33 and 5 U01 HD 74 Reed SJ, Miller RL, Francisco VT, & the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Programmatic capacity and HIV structural change interventions: Influences on coalitions' success and efficiency in accomplishing intermediate outcomes. J Prev Interv Community 40:2, . PMID PMCID 4 30. 5 U01 HD 33 and 5 U01 HD 74 Miller RL, Reed SJ, and the ATN Protocol Team for the Adolescent Trials Network for HIV/AIDS Interventions. Conflict Transformation, Stigma, and HIV-Preventive Structural Change. Am J Commun Psychol, 2 Jun;49(3-4):. PMID PMCID 2 ATN 31. 5 U01 HD 33 and 5 U01 HD 74 Aaron, Kempf, Christenson, Wilson, Muntner, Shrestha, and the Adolescent Medicine Trials Network. Prevalence of Proteinuria and Elevated Serum Cystatin C among HIV-infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) Study. J Acquir Immune Defic Syndr, 2 Dec 1;61(4):. PMID PMCID 3 3 ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SE, Hoffman D, Wilson CM, Cunningham CK and the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). Comprehension of a simplified assent/consent form in a vaccine trial for adolescents. J Med Ethics, 3 Jun;39(6):-2. PMID PMCID 0 ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Bangi AK, Dolcini MM, Harper GW, Boyer CB, Pollack LM and the Adolescent Medicine Trials Network. Psychosocial Outcomes of Sexual Risk Reduction in a Brief Intervention for Urban African American Female Adolescents. J HIV AIDS Soc Serv, 3;12(2):. PMID PMCID 5 ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Clum GA, Czaplicki L, Andrinopoulos K, Muessig K, Hamvas L, Ellen JM, and the Adolescent Medicine Trials Network. Strategies and Outcomes of HIV Status Disclosure in HIV Positive Young Women with Abuse Histories. AIDS Patient Care STDs, 3 Mar;27(3):. PMID PMCID 3 ATN 4. 5 U01 HD 33 and 5 U01 HD 74 Giguere R, Zimet GD, Kahn JA, Dolezal C, Leu CS, Mabragana M, Carballo-Dieguez A, McGowan I, and the Adolescent Medicine Trials Network. The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico. World J AIDS, 3 Sep;3(3). PMID PMCID 1 5. 5 U01 HD 33 and 5 U01 HD 74 Mabragana M, Carballo-Dieguez A, Giguere R on behalf of the ATN and MTN Protocol Teams, and the Adolescent Medicine Trials Network. Young women’s experience with using Videoconferencing for the assessment of sexual behavior and microbicide use. Telemed J E Health, 3 Nov;19(11):-71. PMID PMCID 4 [Available on 4/11/1] ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon C, Mulligan K and the Adolescent Medicine Trials Network. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: Cause of a functional vitamin D deficiency? Antimicrob Agents Chemother, 3 Nov;57(11):9-28. PMID PMCID 9 7. 5 U01 HD 33 and 5 U01 HD 74 Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J, and the Adolescent Medicine Trials Network. Genetic Associations with 25-Hydroxyvitamin D Deficiency in HIV-1-Infected Youth: Fine-Mapping for the GC/DBP Gene That Encodes the Vitamin D-Binding Protein. Front Genet; 4:. PMID PMCID 2 ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Xu J, Kapogiannis B, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires K, and the Adolescent Medicine Trials Network. Immunogenicity and Safety of the HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women. Clin Infect Dis, 3 Sep;57(5):-44. PMID PMCID 3 [Available on 4/9/1] ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Kapogiannis BG, Howell K, Reid S, Lowe J, Ellen JM, and the Adolescent Medicine Trials Network. An Assessment of the Feasibility and Acceptability of a Friendship-Based Social Network Recruitment Strategy to Screen At-Risk African American and Hispanic/Latina Young Women for HIV Infection. JAMA Pediatr, 3 Mar 1;(3):-96. PMID PMCID 7 ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Fernandez MI, Bruce D, Hosek SG, Jacobs RJ, and the ATN. The Role of Multiple Identities in Adherence to Medical Appointments among Gay/Bisexual Male Adolescents Living with HIV. AIDS Behav, 3 Jan;17(1):. PMID PMCID 0 11. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper GW, Fernandez MI, and the Adolescent Medicine Trials Network. Heavy Marijuana Use among Gay and Bisexual Male Emerging Adults Living with HIV/AIDS: A Mixed Methods Study. J HIV/AIDS Soc Serv, 12:26–48, 3. PMID PMCID 2 12. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Harper GW, Suleta K, and the Adolescent Medicine Trials Network. Sexual Risk Behavior and Risk Reduction Beliefs among HIV-positive Young Men who have Sex with Men. AIDS Behav, 3 May;17(4):5-23. PMID PMCID 4 13. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Kahana S, Harper GW, Fernandez MI, and the Adolescent Medicine Trials Network. Alcohol Use Predicts Sexual Risk Behavior With HIV-Negative or Partners of Unknown Status Among Young HIV-Positive Men Who Have Sex With Men. AIDS Care, 3 May;25(5):-65. PMID PMCID 9 ATN 14. 5 U01 HD 33 and 5 U01 HD 74 Nichols SL, Bethel J, Garvie P, Woods SP, Patton D, Thornton S, Kapogiannis BG, Ren W, Li T, Major-Wilson H, Puga A, and the Adolescent Medicine Trials Network. Neurocognitive Functioning in Antiretroviral Therapy-Naïve Youth with Behaviorally Acquired HIV. J Adolesc Health, 3 Dec;53(6):-71. PMID PMCID 5 [Available on 4/12/1] ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Naar-King S, Outlaw AY, Saar M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ, and the Adolescent Medicine Trials Network. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. J Pediatr Psychol, 3 Jul;38(6):-48. (PMID PMCID 5 ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD, and the Adolescent Medicine Trials Network. Preventive Misconception and Adolescents’ Knowledge about HIV Vaccine Trials. J Med Ethics, 3 Dec;39(12):-71. PMID PMCID 6 ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Miller RL, Reed SJ, Francisco V, and the Adolescent Medicine Trials Network. Accomplishing structural change: Identifying intermediate indicators of success. Am J Community Psychol, 3 Mar;51(1-2):-42. PMID PMCID 5 18. 5 U01 HD 33 and 5 U01 HD 74 Reed SJ, Miller RL, and the Adolescent Medicine Trials Network. Connect to Protect® and the Creation of AIDS-Competent Communities. AIDS Educ and Prev, 3;25(3): –. PMID PMCID 5 ATN 19. 5 U01 HD 33 and 5 U01 HD 74 Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, Rutledge B, Martinez J, Garofalo R, Wilson CM, and the Adolescent Medicine Trials Network. Project PrEPare (ATN ): The Acceptability and Feasibility of an HIV Pre-Exposure Prophylaxis (PrEP) Trial with Young Men who Have Sex With Men (YMSM). J Acquir Immune Defic Syndr, 1 April 3;62(4):–. PMID PMCID 1 20. 5 U01 HD 33 and 5 U01 HD 74 Hosek SG, Green KR, Siberry G, Lally M, Kapogiannis B, and the Adolescent Medicine Trials Network. Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago’s Project PrEPare. J HIV AIDS Soc Serv, 12:–, 3 PMID PMCID 4 ATN 21. 5 U01 HD 33 and 5 U01 HD 74 Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW, and the Adolescent Medicine Trials Network. Assessment of biomarkers of cardiovascular risk among HIV-1 infected adolescents: role of soluble Vascular Cell Adhesion Molecule (sVCAM) as an early indicator of endothelial inflammation. AIDS Res Hum Retroviruses, 3 Mar;29(3):. PMID PMCID 4 ATN 22. 5 U01 HD 33 and 5 U01 HD 74 MacDonell K, Naar-King S, Huszti H, Belzer M, and the Adolescent Medicine Trials Network. Barriers to Medication Adherence in Behaviorally and Perinatally Infected Youth Living With HIV. AIDS Behav, 3 Jan;17(1):86-93. PMID PMCID 0 ATN 23. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin MM, Ott MA, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Linking HIV Positive adolescents into care: The effects of relationships between local health departments and adolescent medicine clinics. J HIV AIDS Soc Serv, 3;12(3-4):. PMID PMCID 8 4 ATN a/b 1. 5 U01 HD 33 and 5 U01 HD 74 Rubinstein ML, Harris DR, Rudy BJ, Kapogiannis BG, Aldrovandi GM, Mulligan K, the ATN protocol team, and the Adolescent Medicine Trials Network. Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV. AIDS Res Treat, 4; 4: . PMID PMCID 4 ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Chutuape KS, Muyeed AZ, Willard N, Greenberg L, Ellen JM, and the Adolescent Medicine Trials Network. Adding to the HIV Prevention "Mix" - the Achievement of Structural Change Objectives by 13 Connect to Protect® Coalitions. Glob J Community Psychol Pract, 4 Dec; 5(2):1-8. NIHMS ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, and the Adolescent Medicine Trials Network. Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youth treated with Tenofovir Disoproxil Fumarate. Antivir Ther, 4 19(6):. PMID PMCID 8 [Available on 5/8/17] ATN 4. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Lemos D, Hosek S, and the Adolescent Medicine Trials Network. Stigma Reduction in Adolescents and Young Adults Newly Diagnosed with HIV in the U.S.: Findings from the Project ACCEPT Intervention. AIDS Patient Care STDs, 4 Oct;28(10):-54. PMID PMCID 5 [Available on 5/10/1] ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Esposito-Smythers C, Brown LK, Wolff J, Xu J, and Thornton S for the Adolescent Medicine Trials Network. Substance Abuse Treatment for HIV Infected Young People: An Open Pilot Trial. J Subst Abuse Treat, 4 Feb;46(2):-50. (ATN ) PMID PMCID 2 [Available on 5/2/1] ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Bruce D, Hosek SG, Fernandez MI, Rood B, and the Adolescent Medicine Trials Network. Resilience Processes Demonstrated by Young Gay and Bisexual Men Living with HIV: Implications for Intervention. AIDS Patient Care STDs, 4 Dec;28(12):-76. PMID PMCID 1 [Available on 5/12/1] ATN / 7. 5 U01 HD 33 and 5 U01 HD 74 Nichols SL, Lowe A, Zhang X, Garvie PA, Patton D, Thornton S, Goldberger BA, Hou W, Goodnow MM, Sleasman JW, and the Adolescent Medicine Trials Network. Concordance Between Self-Reported Substance Use and Toxicology Among HIV-Infected and Uninfected At Risk Youth. Drug Alcohol Depend, 4 Jan 1;:-82. PMID PMCID 3 ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Outlaw AY, Naar-King S, Tanney M, Belzer M, Aagenes A, Parsons JT, Greene LM, and the Adolescent Medicine Trials Network. The Initial Feasibility of a Computer-Based Motivational Intervention for Adherence for Youth Newly Recommended to Start Antiretroviral Treatment. AIDS Care, 4 Jan;26(1):-5. PMID PMCID 2 ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Lally M, Goldsworthy R, Sarr M, Kahn JA, Brown LK, Peralta L, Zimet GD, and the Adolescent Medicine Trials Network. Evaluation of an Intervention among Adolescents to Reduce Preventive Misconception in HIV Vaccine Clinical Trials. J Adolesc Health, 4 Aug;55(2):-9. PMID PMCID 3 [Available on 5/8/1] ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur A, Clark L, and the Adolescent Medicine Trials Network. The Use of Cell Phone Support for Non-Adherent HIV-Infected Youth and Young Adults: A Randomized and Controlled Pilot Intervention. AIDS Behav, 4 Apr;18(4):-96. PMID PMCID 9 [Available on 5/4/1] ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Reed SJ, Miller RL, Francisco VT, and the Adolescent Medicine Trials Network. The Influence of Community Context on How Coalitions Achieve HIV-Preventive Structural Change. Health Educ Behav, 4 Feb;41(1):-7. PMID PMCID 0 [Available on 5/2/1] 12. 5 U01 HD 33 and 5 U01 HD 74 Reed SJ, Miller RL, and the Adolescent Medicine Trials Network. The Benefits of Youth Engagement in HIV-Preventive Structural Change Interventions. Youth Soc, 4 Jul;46(4):. PMID PMCID 6 [Available on 5/7/1] ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Kennard B, Brown L, Hawkins L, Risi A, Radcliffe J, Emslie G, Mayes T, King T, Foxwell A, Buyukdura J, Bethel J, Naar-King S, Xu J, Lee S, Garvie P, London C, Tanney M, Thornton S, and the Adolescent Medicine Trials Network. Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV. Cogn Behav Pract, 4 May;21(2),. PMCID 0 ATN 14. 5 U01 HD 33 and 5 U01 HD 74 Whiteley LB, Brown LK, Swenson R, Kapogiannis BG, Harper GW, and the Adolescent Medicine Trials Network. Mental Health Care among HIV Infected Youth in Medical Care: Disparities and Equalities. J Int Assoc Provid AIDS Care, 4 Jan-Feb;13(1):29-34. PMID PMCID 8 ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Brothers J, Harper GW, Fernandez MI, Hosek SG, and the Adolescent Medicine Trials Network. EVOLUTION-Taking Charge and Growing Stronger: The Design, Acceptability & Feasibility of a Secondary Prevention Empowerment Intervention for Young Women Living with HIV. AIDS Patient Care STDs, 4 Jan;28(1):33-42. (ATN ) PMID PMCID 8 ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care. AIDS Care, 4 Jan;26(1):12-9. PMID PMCID 3 17. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis BG, Fortenberry JD, and the Adolescent Medicine Trials Network. ‘Youth friendly’ clinics: Considerations for linking and engaging HIV-infected adolescents into care. AIDS Care, 4 Feb;26(2):. PMID PMCID 4 18. 5 U01 HD 33 and 5 U01 HD 74 Ellen JM, Kapogiannis B, Fortenberry JD, Xu J, Willard N, DuVal A, Pace J, Loeb J, Monte D, Bethel J, and the Adolescent Medicine Trials Network. HIV Viral Load Levels and CD4+ Cell Counts of Youth in Fourteen U.S. Cities. AIDS, 4 May 15;28(8):3-9. PMID PMCID 1 19. 5 U01 HD 33 and 5 U01 HD 74 Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen Adolescent Medicine Clinics in the United States. AIDS Behav, 4 Aug;18(8): 1-10. PMID PMCID 3 [Available on 5/8/01] ATN 20. 5 U01 HD 33 and 5 U01 HD 74 Boyer C, Robles-Schrader G, Li SX, Miller R, Korelitz J, Price GN, Rivera Torres C, Chutuape K, Stines S, Straub D, Peralta L, Febo I, Hightow-Weidman L, Gonin R, Kapogiannis B, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. A Comparison of Network-based Strategies for Screening At-Risk Hispanic/Latino Adolescents and Young Adults for Undiagnosed Asymptomatic HIV Infection. J Adolesc Health, 4 Dec;55(6):-73. PMID PMCID 9 [Available 5/12/1] ATN 21. 5 U01 HD 33 and 5 U01 HD 74 Savel C, Mierzwa S, Gorbach P, Lally M, Zimet G, Meyer K, Souidi S, and the Adolescent Trials Network for HIV/AIDS Interventions. Web-based, mobile-device friendly, self-report survey system incorporating avatars and gaming console techniques. Online J Public Health Inform, 4 6(2):e. 5 ATN b 1. 5 U01 HD 33 and 5 U01 HD 74 Lee S, Yamazaki M, Harris DR, Harper G, Ellen J, and the Adolescent Medicine Trials Network. Social Support and Human Immunodeficiency Virus-Status Disclosure to Friends and Family: Implications for Human Immunodeficiency Virus-Positive Youth. J Adolesc Health, 5 Jul;57(1):73-80. PMID PMCIS 2 [Available on 6-07-01] 2. 5 U01 HD 33 and 5 U01 HD 74 Alcantara L, Harper GW, Keys CB, and the Adolescent Medicine Trials Network. “There’s Gotta be Some Give and Take”: Community Partner Perspectives on Benefits and Contributions associated with Community-Researcher Partnerships. Youth Soc, 5 Jul:47(1):. PMID PMCID 0 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC0/ ATN b 3. 5 U01 HD 33 and 5 U01 HD 74 Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB, Gonin R, and the Adolescent Medicine Trials Network. Evaluation of the effect of HIV-related Structural Interventions: the connect to protect project JAMA Pediatr, 5 Mar 1;(3):-63. PMID PMCID 0 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC0/ 4. 5 U01 HD 33 and 5 U01 HD 74 Ellen JM, Greenberg N, Willard N, Stines S, Korelitz J, Boyer CB and the Adolescent Trials Network for HIV/AIDS Interventions. Cross-sectional survey comparing HIV risk behaviors of adolescent and young adult men who have sex with men only and men who have sex with men and women in the US and Puerto Rico. Sex Transm Infect, 5 Sep;91(6):-61. PMID PMCID 2 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2/ ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Emmanuel P, Price G, Hudey S, Goodenow M, Sleasman J, and the Adolescent Medicine Trials Network. Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 > in ATN . J Acquir Immune Defic Syndr, 5 May 1;69(1):52-60. PMID PMCID 1 [Available on 6-05-01] ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Hussen SA, Harper GW, Bauermeister J, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Psychosocial influences on engagement in care among HIV-positive young Black gay/bisexual and other men who have sex with men. AIDS Patient Care STDs, 5 Feb;29(2):77-85. PMID PMCID 8 [Available on 6-02-01] ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Decision Making about Participation in a Hypothetical HIV Vaccine Trial. Vaccine, 5 Mar 10;33(11):1-7. PMID PMCID 7 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7/ ATN 8. 5 U01 HD 33 and 5 U01 HD 74 Belzer M, Mac-Donnell-Kolmodin K, Clark L, Huang J, Olson J, Kahana S, Naar-King S, Sarr M, Thornton S, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Non-adherence to Antiretroviral Therapy. AIDS Patient Care STDs, 5 Jun;29(6):. PMID PMC Journal PMCID 0 [Available on 6-06-01] ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Havens PL, Hazra R. The Place of Tenofovir Disoproxil Fumarate in Pediatric Antiretroviral Therapy. Pediatr Infect Dis J, 5 Apr;34(4):-8. (editorial that highlights ATN ) PMID PMCID 6 [Available on 6-04-01] ATN 10. 5 U01 HD 33 and 5 U01 HD 74 Kahana SY, Fernandez MI, Wilson PA, Lee S, Bauermeister JA, Wilson CM, Hightow-Weidman LB, the ATN Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Rates and Correlatesof Antiretroviral Therapy Use and Virologic Suppression Among Perinatally and Behaviorally HIV-Infected Youth Linked to Care in the United States. J Acquir Immune Defic Syndr, 5 Feb; 68(2):-77. PMID PMCID 7 [Available on 6-02-01] 11. 5 U01 HD 33 and 5 U01 HD 74 Saberi P, Mayer K. Vittinghoff E, Naar-King S, and the Adolescent Medicine Trials Network. Correlation between Use of Antiretroviral Adherence Devices by HIV-infected Youth and Plasma HIV RNA and Self-reported Adherence. AIDS Behav, 5 Jan; 19(1): 93-. PMID PMCID 9 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9/ 12. 5 U01 HD 33 and 5 U01 HD 74 Brown LK, Whitely L, Harper GW, Nichols S, Nieves A, the ATN Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Psychological Symptoms among 2, Youth Living with HIV. AIDS Patient Care STDs, 5 Apr;29(4):. PMID PMCID 6 [Available on 6-04-01] 13. 5 U01 HD 33 and 5 U01 HD 74 Cook SH, Velera P, Wilson PA and the Adolescent Trials Network for HIV/AIDS Interventions. HIV Status Disclosure, Depressive Symptoms, and Sexual Risk Behavior among HIV-Positive Young Men Who Have Sex with Men. J Behav Med, 5 Jun;38(3):-17. PMID PMCID 1 [Available on 6-06-01] 14. 5 U01 HD 33 and 5 U01 HD 74 Fernandez MI, Huszti HC, Wilson PA, Kahana S, Nichols SL, Gonin R, Xu J, Kapogiannis BG, the ATN Protocol Team, and the Adolescent Medicine Trials Network. Profiles of Risk Among HIV-Infected Youth in Clinic Settings. AIDS Behav, 5 May;19(5):-30. PMID PMCID 0 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC0/ 15. 5 U01 HD 33 and 5 U01 HD 74 Boone MR, Cherenack EM, Wilson PA, ATN Protocol Team, and the Adolescent Medicine Trials Network. Self-Efficacy and Sero-sorting as Correlates of Sexual Risk Behavior among HIV-Positive Adolescent Girls and Women. AIDS Patient Care STDs, 5 Jun;29(6):. PMID PMC Journal PMCID 3 [Available on 6-06-01] 16. 5 U01 HD 33 and 5 U01 HD 74 Bruce D, Kahana S, Bauermeister J, Nichols S, Hightow-Weidman L, Heinze J, Shea J, Fernandez I, and the Adolescent Trials Network for HIV/AIDS Interventions. Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS. Drug Alcohol Depend, 5 Jun 1;:-80. PMID PMCID 7 [Available on 6-06-01] ATN 17.5 U01 HD 33 and 5 U01 HD 74 Chutuape K, Willard N, Cooper-Walker B, Boyer CB, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. A Tailored Approach to Launch Community Coalitions focused on Achieving Structural Changes: Lessons Learned from HIV Prevention Mobilization Study. J Public Health Manag Pract, 5 Dec;21(6):. PMID PMCID 6 NIHMS [Available on 6-11-01] ATN 18.5 U01 HD 33 and 5 U01 HD 74 Willard N, Chutuape K, Campbell-Stewart R, Boyer CB, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Targeting Structural Change for HIV Prevention: A Process and Tool for Community Application. Health Promot Pract, 5 Nov;16(6):-48. PMID PMCID 6 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6/ ATN 19. 5 U01 HD 33 and 5 U01 HD 74 Mullins TL, Lally M. Zimet G, Kahn JA and the Adolescent Trials Network for HIV/AIDS Interventions. Clinician Attitudes toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents. AIDS Patient Care STDs, 5 Apr;29(4):. PMID PMCID 2 [Available on 6-04-01] ATN 20. 5 U01 HD 33 and 5 U01 HD 74 Gilbert AL, Knopf A, Fortenberry JD, Hosek SG, Kapogiannis BG, Zimet GD, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Self-Consent for Biomedical HIV Prevention Research: Implications for Institutional Review Board Approval and Implementation. J Adolesc Health, 5 Jul;57(1):. PMID PMCID 4 [Available on 6-07-01] ATN 21. 5 U01 HD 33 and 5 U01 HD 74 Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML, and the Adolescent Medicine Trials Network. Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Adolescents. Sex Transm Dis, 5 May;42(5):-52. PMID PMCID 1 [Available on 6-05-01] 6 ATN b 1. 5 U01 HD 33 and 5 U01 HD 74 Miller R, Janulis P, Reed S, Harper G, Ellen J, Boyer C, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Creating youth-supportive communities: Outcomes from the Connect-to Protect® (C2P) structural change approach to youth HIV prevention. J Youth Adolesc, 6 Feb;45(2):-15. PMID PMCID 6 [Available on 7-02-01] ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Brown L, Kennard B, Emslie G, Mayes T, Whitley L, Bethel J, Xu J, Thornton S, Tanney M, Hawkins L, Garvie P, Subramaniam GA, Worrell C, Stoff L and the Adolescent Trials Network for HIV/AIDS Interventions. Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults living with HIV: A controlled trial. J Acquir Immune Defic Syndr, 6 Jan;71(1):38-46. NIHMS . PMID PMCID 3 [Available on 7-01-01] ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Wilson P, Kahana S, Fernandez MI, Harper G, Mayer K, Wilson C, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual Risk Behavior among Virologically Detectable HIV-Positive Young Men Who Have Sex With Men. JAMA Pediatrics, 6;(2):. PMID PMC – In Process Accepted Scientific Papers ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Serrano PA, Bruce D. The Internet’s Multiple Roles in Facilitating the Sexual Orientation Identity Development of Gay/Bisexual Male Adolescents. Am J Mens Health, in press. Accepted 12/08/14. PMID PMC - In Process ATN 2. 5 U01 HD 33 and 5 U01 HD 74 Ruan A, Tobin NH, Mulligan K, Li F, Sleasman J, Aldrovandi GM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Macrophage Activation in HIV-infected Adolescent Males Contributes to Differential None Loss by Sex: Adolescent Trials Network Study . J Acquir Immune Defic Syndr, in press. Accepted 02/01/16. NIHMS ATN 3. 5 U01 HD 33 and 5 U01 HD 74 Nichols S, Bethel J, Kapogiannis B, Woods S, Patton E. D., Ren W, Thornton S, Major-Wilson H, Puga A, Sleasman J, Rudy B, Wilson C, Garvie P, and the Adolescent Trials Network for HIV/AIDS Interventions. Neurocognitive functioning following initiation of antiretroviral therapy in youth with behaviorally acquired HIV. J Neurovirol, in press. Accepted 09/21/15. PMID NIHMS ATN 4. 5 U01 HD 33 and 5 U01 HD 74 Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, Rubin D and the Adolescent Trials Network for HIV/AIDS Interventions. Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked to and Engaged in Medical Care. LGBT Health, in press. Accepted 12/22/14. NIHMS . PMID PMCID 8 [Available on 6-09-11] 5. 5 U01 HD 33 and 5 U01 HD 74 MacDonell KK, Tiura AJ, Naar-King S, Fernandez MI, and the Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Adherence to Antiretroviral Medication in a Multi-Site Study of Ethnic and Racial Minority Youth. J Pediatr Psychol, in press. Accepted 09/24/15. PMID PMC – In Process ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Brothers J, Hotton A, Hosek S, Fernandez MI, Harper G and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Women Living With HIV: Outcomes from a Targeted Secondary Prevention Empowerment Pilot Trial. AIDS Patient Care STDs, in press. Accepted 02/29/16. PMC Journal – In Process ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Philbin M, Tanner AE, DuVal A, Ellen J, Xu J, Kapogiannis B, Bethel J, Fortenberry D, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. How time between HIV testing, care referral and linkage to care affects time to, and rates of, engagement in care for newly diagnosed HIV-infected adolescents in fifteen adolescent medicine clinics in the United States. J Acquir Immune Defic Syndr, in press. Accepted 02/05/16. NIHMS ATN - 8. 5 U01 HD 33 and 5 U01 HD 74 Boyer CB, Walker BC, Chutuape KS, Roy JR, Fortenberry DJ, and the Adolescent Trials Network for HIV/AIDS Interventions. Creating Systems Change to Support Goals for HIV Continuum of Care: The Role of Community Coalitions to Reduce Structural Barriers for Adolescents and Young Adults. J HIVAIDS Soc Serv, in press. Accepted 02/28/15. PMC – In Process ATN 9. 5 U01 HD 33 and 5 U01 HD 74 Cherenack EM, Wilson PA, Kreuzman A, Price G and the Adolescent Trials Network for HIV/AIDS Interventions. The Feasibility and Acceptability of Using Technology-Based Daily Diaries with HIV-Infected Young Men who have Sex with Men: A Comparison of Internet and Voice Modalities. Approved by the BLG 01/09/15. AIDS Behav, in press. Accepted 01/17/16.PMID PMC – In Process ATN 10. 5 U01 HD 33, 5 U01 HD 74, and 5 U01 HD42 Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. AIDS, in press. Accepted 12/01/15. NIHMS Submitted Manuscripts
ATN 1. 5 U01 HD 33 and 5 U01 HD 74 Harper GW, Bruce D, Wilson BDM, Motley D, Jamil OB, Torres RS, Hidalgo MA, Brodsky A, Fernandez MI, and the Adolescent Trials Network for HIV/AIDS Interventions. An Empirically-Based Transactional Model of Same-Sex Sexual Orientation. Approved by BLG 05/30/14. Submitted to Psychol Sex Orientat Gend Divers 02/10/15. Author checked in May, July, and September; manuscript still under review 09/08/15. ATN b 2. 5 U01 HD 33 and 5 U01 HD 74 Sanders R, Fields E, Greenberg L, Henry-Reid L, Stines S, Korelitz J, Kapogiannis B, Ellen J, Boyer C, and the Adolescent Trials Network for HIV/AIDS Interventions. Association between Recruitment Venue Type and HIV-Related Risk Behavior among Adolescent and Young Adult Men Who Have Sex with Men. Approved by CPLG 07/16/14. Submitted to AIDS Behav 08/11/14. Not accepted 11/18/14. Revised manuscript submitted for CPLG re-review due to significant changes 03/13/15. Approved by CPLG 03/26/15. Submitted to J Adolesc Health 04/30/15. Not accepted 07/08/15. Revised manuscript submitted to Health & Place 09/12/15. Not accepted 11/17/15. 3. 5 U01 HD 33 and 5 U01 HD 74 Boyer C, Greenberg L, Korelitz J, Harper G, Stewart-Campbell R, Straub D, Arrington-Sanders R, Henry-Reid L, Futterman D, Lee S , Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Sexual Partner Characteristics, Relationship Type, and HIV Risk Among A Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex With Men. Approved by CPLG 08/18/15. Submitted to the Journal of Urban Health 09/28/15. Not accepted 10/23/15. Submitted to AIDS Behav 10/30/15. Not accepted 01/11/16. Submitted to Youth Soc 03/02/16. ATN 4. 5 U01 HD 33 and 5 U01 HD 74 Ventuneac A, Xu J, Liu N, Zimet G, Kapogiannis B., Khan J, and the Adolescent Trials Network for HIV/AIDS Interventions. Employing an Interactive Voice Response System to Capture Adverse Event Data in a Human Papillomavirus Vaccination Trial for HIV-Infected Adolescent and Young Adult Women. Approved by TLG 12/18/14. Submitted to Contemp Clin Trials 02/11/15. Not accepted 03/23/15. Submitted to Clin Trials 04/15/15. Due to a computer error the manuscript had to be resubmitted to Clin Trials 08/26/15. Not accepted. Submitted to the J Mob Technol Med on 11/15/15. Not accepted ATN 5. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Timmons A, Bruce D, Graham L, Wade R, and the Adolescent Trials Network for HIV/AIDS Interventions. Drugs, Sex, and Condoms: Cultural Messages Influencing Young Black Gay and Bisexual Men Living with HIV. Approved by BLG 02/25/15. Submitted to Cultur Divers Ethnic Minor Psychol 05/12/15. Revise and resubmit requested by journal 07/16/15. Journal granted resubmission due date extension to 11/16/15 (10/29/15). ATN 6. 5 U01 HD 33 and 5 U01 HD 74 Belzer M, McDonell KK, Xu J, Olson J, Naar-King S, Clark L, Dowshen N, Vandenberg J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. A Randomized, Controlled Pilot Study of Cell Phone Support for Youth Nonadherent to ART: Impact on Depression, Substance Abuse and Perceived Stress. Approved by BLG 11/20/15. Submitted 02/12/16 to AIDS Patient Care STDs. ATN 7. 5 U01 HD 33 and 5 U01 HD 74 Hightow-Weidman LB, Boyer CB, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Siberry G, Kapogiannis BG, Ellen J, and the Adolescent Medicine Trials Network. Feasibility of Recruiting the Male Sexual Partners of HIV-positive and Negative Black and Hispanic Young Women to Undergo HIV Testing. Submitted to but not accepted by Sex Transm Infect, Sex Transm Dis, J Adol Health, AIDS Patient Care STDs and AIDS Educ Prev. CPLG recommended team shorten manuscript to a brief report (06/23/14). Team reviewing journal options for next submission 07/08/14. Submitted to Health Educ Behav 08/04/5. Author requested update from journal 12/13/15. Not accepted. Author has decided not to submit the manuscript to another journal 02/18/16. ATN 8. 5 U01 HD 33 and 5 U01 HD 74 van den Berg J, Fernandez MI, Fava J, Rudy B, Wilson P, and the Adolescent Trials Network for HIV/AIDS Interventions. Developing and Testing a Conceptual Model Predicting Unprotected Sex among Youth Living with HIV in 17 U.S. Cities. Approved by the BLG 02/26/15. Submitted to Am J Public Health 04/01/15. Not accepted 04/07/15. Submitted to Health Psychol 04/15/15. Not accepted. Revised manuscript submitted to AIDS and Behavior 09/22/15. Revise and resubmit requested by journal 12/29/15. 9. 5 U01 HD 33 and 5 U01 HD 74 Kahana S, Jenkins R, Douglas B, Fernandez MI, Hightow-Weidman L, Bauermeister J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Neighborhood Determinants of Viral Suppression, Antiretroviral Therapy Use, and HIV Care Among Youth and Young Adults with HIV. Approved by BLG 08/19/15. Submitted to PLOS One 10/10/15. Revise and resubmit requested by journal 11/23/15. Revised manuscript resubmitted 02/19/16. Provisionally accepted 02/24/16. 10. 5 U01 HD 33 and 5 U01 HD 74 Gross I, Hosek S, Richards M, Fernandez MI, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Predictors and Profiles of Antiretroviral Therapy Adherence among African-American Adolescents and Young Adult Males Living with HIV. Approved by BLG 09/25/15.Submitted to AIDS and Behavior 11/06/15. Not accepted. Submitted to AIDS Care 12/03/15. Not accepted. Submitted to AIDS Patient Care STDs 12/15/15. ATN 11. 5 U01 HD 33 and 5 U01 HD 74 Wilson P, Cherenack E, Jadwin-Cakmak L, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Selection and Evaluation of Media for Behavioral Interventions Employing Critical Media Analysis. Approved by BLG 07/31/14. Submitted to Health Promot Pract 08/27/14. Revise and resubmit requested by journal 01/09/15. Authors granted an extension to 02/23/15 for revise and resubmit deadline (02/10/15). Revised manuscript resubmitted 02/27/15. Accepted pending minor revisions 05/26/15. Revised manuscript submitted 06/18/15. Journal requested additional minor revisions 08/10/15. Revised manuscript resubmitted 08/24/15. 12. 5 U01 HD 33 and 5 U01 HD 74 Harper G, Jadwin-Cakmak L, Cherenack E, Wilson P, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Critical Consciousness HIV Prevention Intervention for Black Gay/Bisexual Young Men. Approved by BLG 06/05/15. Submitted to the journal Culture, Health and Sexuality 08/25/15. Author withdrew manuscript due to word limit requirements and will revise manuscript for submission to Youth & Society 09/08/15. ATN 13. 5 U01 HD 33 and 5 U01 HD 74 Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Transitioning HIV-positive adolescents to adult care: Lessons learned from twelve adolescent medicine clinics. Approved by CPLG 02/27/14. Submitted to JAMA Pediatr, J Adolesc Health, and AIDS Care. Not accepted. Submitted to J Int AIDS Soc 06/16/15. Not accepted 07/24/15. Submitted to the J Pediatr Nurs 08/25/15. Revised manuscript submitted 10/15/15. Additional revisions requested by journal 12/15/15. Revised manuscript submitted 12/21/15. Additional minor revisions requested 02/08/16. Revised manuscript resubmitted 02/15/16. ATN 14. 5 U01 HD 33 and 5 U01 HD 74 Hosek S, Rudy B, Landovitz R, Kapogiannis B, Rutledge B, Liu N, Brothers J, Mulligan K, Lally M, Zimet G, Mayer K, Rooney J, Wilson CM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM ages 18-22 in the United States. Approved by the CPLG 1/15/16 Submitted to J Acquir Immune Defic Syndr 01/31/16. ATN 15. 5 U01 HD 33 and 5 U01 HD 74 Mullins TL, Zimet G, Lally M., Kahn JA and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adolescent HIV Care Providers’ Attitudes toward the Use of Oral Pre-Exposure Prophylaxis (PrEP) in Youth. Approved by CPLG 01/06/16.Submitted to AIDS and Behav 02/01/6. Not accepted. Submitted to AIDS Patient Care STDs 03/02/16. ATN 16. 5 U01 HD 33 and 5 U01 HD 74 Knopf, Lewis-Gilbert, Hosek, Kapogiannis, Fortenberry, Ott, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Moral conflict and competing duties in the initiation of a biomedical HIV prevention trial with minor adolescents. Approved by CPLG 10/30/15. Submitted to Am J Bioeth 11/16/15. Revise and resubmit requested by journal 02/11/16. ATN 17. 5 U01 HD 33 and 5 U01 HD 74 Kahn J, Rudy B, Xu J, Kapogiannis B, Secord E, Gillison M, and the Adolescent Trials Network for HIV/AIDS Interventions. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth. Approved by the TLG 02/09/15. Submitted to J Acquir Immune Defic Syndr 03/17/15. Not accepted 04/19/15. Submitted to J Infect Dis 04/24/15. Not accepted. Submitted to AIDS Patient Care STDs 08/21/15. Not accepted 08/25/15. Submitted to AIDS Res Hum Retroviruses 08/27/15. Not accepted. Submitted to J Med Virol 01/16/16. Pending Submission
None.